Jump to content

AXA/2025/FY/Earnings presentation: Difference between revisions

From Insurer Brain
< AXA
Content deleted Content added
PlumBot: publish from draft
PlumBot: publish from draft
Line 9: Line 9:
| pages = 49
| pages = 49
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf
| archive_file = File:AXA-2025-FY-Earnings_presentation.md
| intro_sentence = This article summarizes AXA's full-year 2025 earnings presentation, published on 26 February 2026.
| intro_sentence = This article summarizes AXA's full-year 2025 earnings presentation, published on 26 February 2026.
}}
}}
Line 17: Line 16:
== Front matter ==
== Front matter ==


=== Full Year 2025 Earnings Presentation ===
=== Full Year 2025 earnings presentation ===


* '''Presentation date''' February 26, 2026 <sup>p. 1</sup>
* '''Earnings presentation''' for Full Year 2025, delivered on February 26, 2026 <sup>p. 1</sup>


=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures ===
=== IMPORTANTLEGALINFORMATIONANDCAUTIONARYSTATEMENTSCONCERNINGFORWARD-LOOKINGSTATEMENTSANDTHEUSEOF NON-GAAPFINANCIALMEASURES ===


* '''Forward-looking statements''' include predictions, trends, plans, expectations, or objectives, specifically expected underlying earnings per share (UEPS) growth for 2026 provided as one-off guidance for the final year of the Group's strategic plan <sup>p. 2</sup>.
* '''Forward-looking statements''' disclaimer covers predictions, plans, targets, and expectations, specifically noting that statements regarding expected '''underlying earnings per share (UEPS)''' growth for 2026 are forward-looking statements providing one-off guidance for the final year of the Group's current strategic plan <sup>p. 2</sup>.
* '''Risk factors''' and uncertainties that may affect AXA's business are described in Part 5 of AXA's Universal Registration Document for the year ended December 31, 2024 <sup>p. 2</sup>.
* '''Risk factors''' and uncertainties that may affect AXA's business are described in Part 5 "Risk Factors and Risk Management" of AXA's Universal Registration Document for the year ended December 31, 2024 <sup>p. 2</sup>.
* '''Non-GAAP measures''' and alternative performance measures (APMs) used include "Underlying earnings", UEPS, "underlying return on equity", "combined ratio", and "debt gearing" <sup>p. 2</sup>.
* '''Non-GAAP measures''' and alternative performance measures (APMs) used include "Underlying earnings", UEPS, "underlying return on equity", "combined ratio", and "debt gearing" <sup>p. 2</sup>.
* '''APM reconciliations''' are provided in AXA's Activity Report as of December 31, 2025, available on www.axa.com <sup>p. 2</sup>.
* '''APM reconciliations''' are provided in AXA's Activity Report as of December 31, 2025, under the heading "Use of non-GAAP and alternative performance measures" <sup>p. 2</sup>.
* '''Financial statements''' for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to audit completion <sup>p. 2</sup>.
* '''Financial statements''' for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of an audit procedure by statutory auditors <sup>p. 2</sup>.


=== Table of contents ===
=== Table of contents ===


* '''FY25 Highlights''' presented by Thomas Buberl, Group CEO <sup>p. 3</sup>
* '''FY25 Highlights''' presented by Thomas Buberl, Group CEO <sup>p. 3, 4</sup>
* '''FY25 Business Performance''' presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 3</sup>
* '''FY25 Business Performance''' presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 3, 9</sup>
* '''FY25 Financial Performance''' presented by Alban de Mailly Nesle, Group CFO <sup>p. 3</sup>
* '''FY25 Financial Performance''' presented by Alban de Mailly Nesle, Group CFO <sup>p. 3, 13</sup>


== FY25 Highlights ==
== FY25 Highlights ==


* '''Section title''': 1 FY25 Highlights presented by Thomas Buberl, Group CEO <sup>p. 4</sup>
* '''Section divider''': FY25 Highlights presented by Thomas Buberl, Group CEO <sup>p. 4</sup>


=== Full Year 2025 | Excellent performance ===
=== Full Year 2025 | Excellent performance ===
Line 45: Line 44:
|+ Key financial highlights, FY25 <sup>p. 5</sup>
|+ Key financial highlights, FY25 <sup>p. 5</sup>
! style="text-align:left" | Metric
! style="text-align:left" | Metric
! class="col-s" style="text-align:right" | Value
! class="col-m" style="text-align:right" | Value
! class="col-s" style="text-align:right" | Change vs. FY24
|-
|-
| style="text-align:left" | Revenues
| style="text-align:left" | Revenues
| style="text-align:right" | —
| style="text-align:right" | +6%
| style="text-align:right" | +6%
|-
|-
| style="text-align:left" | Underlying EPS
| style="text-align:left" | Underlying EPS
| style="text-align:right" | —
| style="text-align:right" | +8%
| style="text-align:right" | +8%
|-
|-
| style="text-align:left" | Return on equity
| style="text-align:left" | Return on equity
| style="text-align:right" | 16%
| style="text-align:right" | 16%
| style="text-align:right" | —
|-
|-
| style="text-align:left" | Solvency II ratio
| style="text-align:left" | Solvency II ratio
| style="text-align:right" | 224%
| style="text-align:right" | 224%
|-
| style="text-align:right" | —
| style="text-align:left" | Dividend per share growth
| style="text-align:right" | +8%
|-
| style="text-align:left" | Share buyback
| style="text-align:right" | EUR 1.25bn
|-
| style="text-align:left" | Underlying EPS growth target for 2026
| style="text-align:right" | 6% to 8% (upper end)
|}
|}
</div>
</div>
* '''Revenues''' +6% vs. FY24 <sup>p. 5</sup>
* Shareholder value delivered via +8% DPS growth and EUR 1.25bn annual share buyback
* '''Underlying EPS''' +8% vs. FY24 <sup>p. 5</sup>
** Dividend proposal based on Board of Directors' recommendation on February 25, 2026, subject to approval at the Shareholders' Annual General Meeting on April 30, 2026
** Share buyback approved by the Board of Directors on February 25, 2026, expected to commence as soon as reasonably practicable, subject to market conditions
* '''Dividend per share''' +8% growth, based on the dividend proposed by AXA's Board of Directors on February 25, 2026, subject to approval by the Shareholders' Annual General Meeting on April 30, 2026 <sup>p. 5</sup>
* Underlying EPS growth target for 2026 expected at the upper end of the 6%-8% range


=== Executing the plan on growth, margin and efficiency ===
=== Executing the plan on growth, margin and efficiency ===
Line 74: Line 76:
<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| class="wikitable fintable"
{| class="wikitable fintable"
|+ Underlying earnings and growth, FY24 vs FY25 <sup>p. 6</sup>
|+ Underlying earnings, FY24 vs FY25 <sup>p. 6</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change at constant FX
! class="col-s" style="text-align:right" | Change (constant FX)
! class="col-s" style="text-align:right" | Change excluding AXA IM
! class="col-s" style="text-align:right" | Change (excluding AXA IM)
|-
|-
| style="text-align:left" | Underlying earnings
| style="text-align:left" | Underlying earnings
Line 88: Line 90:
|}
|}
</div>
</div>
* High organic growth of +6% top line growth, well balanced across lines: P&C +5%, Life +9%, Health +5%
* Top line growth +6% at constant scope and FX, balanced across lines: P&C +5%, Life +9%, Health +5%
* Record profitability driven by further margin expansion in P&C and L&H, alongside improvement in efficiency
* Margin expansion in P&C and L&H, alongside efficiency improvements
* Scaling the business through continued investments in growth and technology
* Business scaling supported by continued investments in growth and technology
* Consistent earnings growth while enhancing reserve prudence
* Earnings growth remained consistent while enhancing reserve prudence


=== Diversified franchise, well positioned in an attractive industry ===
=== Diversified franchise, well positioned in an attractive industry ===
Line 97: Line 99:
<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| class="wikitable fintable"
{| class="wikitable fintable"
|+ Business mix based on FY25 gross written premium split <sup>p. 7</sup>
|+ FY25 gross written premium split <sup>p. 7</sup>
! style="text-align:left" | Segment
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
! class="col-s" style="text-align:right" | Share
Line 109: Line 111:
| style="text-align:left" | Large & Specialty
| style="text-align:left" | Large & Specialty
| style="text-align:right" | 17%
| style="text-align:right" | 17%
|-
| style="text-align:left" | SME & Mid-market
| style="text-align:right" | 16%
|-
|-
| style="text-align:left" | Retail
| style="text-align:left" | Retail
| style="text-align:right" | 17%
| style="text-align:right" | 17%
|-
| style="text-align:left" | SME & Mid-market
| style="text-align:right" | 16%
|}
|}
</div>
</div>


* '''Secular trends''' are fueling demand across businesses, driven by protection gaps, emerging corporate risks, and demographics driving demand for private retirement and healthcare.
* '''Secular trends''' fuel demand across businesses, driven by protection gaps, emerging corporate risks, and demographics driving demand for private retirement and healthcare.
* '''Our right to win''' is supported by four key pillars:
* '''Our right to win''' is supported by four strategic pillars:
** Leading brand & high customer NPS
** Leading brand & high customer NPS
** Strong and diversified distribution
** Strong and diversified distribution
Line 128: Line 130:


* '''Strategic pillars''' established to lay the foundation for the next plan <sup>p. 8</sup>:
* '''Strategic pillars''' established to lay the foundation for the next plan <sup>p. 8</sup>:
** '''Clear tech and AI roadmap''' <sup>p. 8</sup>
** Clear tech and AI roadmap <sup>p. 8</sup>
** '''Driving efficiency''' <sup>p. 8</sup>
** Driving efficiency <sup>p. 8</sup>
** '''Enhancing capital allocation''' discipline <sup>p. 8</sup>
** Enhancing capital allocation discipline <sup>p. 8</sup>
** '''Building resilience''' <sup>p. 8</sup>
** Building resilience <sup>p. 8</sup>
* '''Earnings growth outlook''' supported by these pillars, providing confidence in sustaining earnings growth <sup>p. 8</sup>
* '''Earnings growth outlook''' supported by these pillars, providing confidence in sustaining earnings growth <sup>p. 8</sup>


=== FY25 Business Performance ===
== FY25 Business Performance ==


* '''Section divider''' for Part 2: "FY25 Business Performance" presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>.
* '''Section 2''': FY25 Business Performance presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>.

== FY25 Business Performance ==


=== Strong delivery across our businesses ===
=== Strong delivery across our businesses ===

* '''Premium growth basis''': change for gross written premiums is at constant scope and FX <sup>p. 10</sup>.
* '''Earnings growth basis''': change for underlying earnings is at constant FX <sup>p. 10</sup>.
* '''Total GWP definition''': FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers <sup>p. 10</sup>.


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| class="wikitable fintable"
{| class="wikitable"
|+ Gross written premiums and underlying earnings by region <sup>p. 10</sup>
|+ Business performance by region FY25 <sup>p. 10</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! style="text-align:left" | Region
! class="col-s" style="text-align:right" | % of total GWP
! class="col-m" style="text-align:right" | Gross written premiums
! class="col-s" style="text-align:right" | GWP
! class="col-m" style="text-align:right" | Underlying earnings
! class="col-s" style="text-align:right" | GWP change
! class="col-s" style="text-align:right" | Underlying earnings
! class="col-s" style="text-align:right" | Underlying earnings change
|-
|-
| style="text-align:left" | France
| style="text-align:left" | France (27% of total GWP¹)
| style="text-align:right" | 27%
| class="col-m" style="text-align:right" | +6% to EUR 31bn
| style="text-align:right" | 31
| class="col-m" style="text-align:right" | +7% to EUR 2.2bn
| style="text-align:right" | +6%
| style="text-align:right" | 2.2
| style="text-align:right" | +7%
|-
|-
| style="text-align:left" | Europe
| style="text-align:left" | Europe (38% of total GWP¹)
| style="text-align:right" | 38%
| class="col-m" style="text-align:right" | +6% to EUR 43bn
| style="text-align:right" | 43
| class="col-m" style="text-align:right" | +9% to EUR 3.5bn
| style="text-align:right" | +6%
| style="text-align:right" | 3.5
| style="text-align:right" | +9%
|-
|-
| style="text-align:left" | AXA XL
| style="text-align:left" | AXA XL (17% of total GWP¹)
| style="text-align:right" | 17%
| class="col-m" style="text-align:right" | +4% to EUR 19bn
| style="text-align:right" | 19
| class="col-m" style="text-align:right" | +9% to EUR 1.9bn
| style="text-align:right" | +4%
| style="text-align:right" | 1.9
| style="text-align:right" | +9%
|-
|-
| style="text-align:left" | Asia, Africa & EME-LATAM
| style="text-align:left" | Asia, Africa & EME-LATAM (18% of total GWP¹)
| style="text-align:right" | 18%
| class="col-m" style="text-align:right" | +13% to EUR 20bn
| style="text-align:right" | 20
| class="col-m" style="text-align:right" | +6% to EUR 1.5bn
| style="text-align:right" | +13%
| style="text-align:right" | 1.5
| style="text-align:right" | +6%
|}
|}
</div>
</div>

* '''Gross written premiums''' change is at constant scope and FX
* '''Underlying earnings''' change is at constant FX
* '''Total GWP''' basis excludes AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers for FY25 gross written premiums


=== P&C | Strong margins, confidence in sustaining growth ===
=== P&C | Strong margins, confidence in sustaining growth ===


* (donut) '''Gross written premiums''' (GWP): EUR 58bn total; segments include Retail, AXA XL (Large & Specialty), and SME & Mid-market (shares not labeled) <sup>p. 11</sup>
<div style="overflow-x:auto">
** '''AXA XL premiums''' include AXA XL Re premiums of EUR 2.6bn <sup>p. 11</sup>
{| class="wikitable fintable"
|+ GWP mix <sup>p. 11</sup>
* '''Underlying earnings''' +9% at constant FX to EUR 5.9bn <sup>p. 11</sup>
* '''Retail and SME''' & Mid-market strategic outlook:
! style="text-align:left" | Segment
** '''2025 focus''': Growing volumes while expanding margins <sup>p. 11</sup>
! class="col-s" style="text-align:right" | Share
** '''Beyond 2025 focus''': Investing to improve customer retention and expanding distribution footprint <sup>p. 11</sup>
|-
* '''AXA XL''' (Large & Specialty) strategic outlook:
| style="text-align:left" | Retail
** '''2025 focus''': Profitable growth with stable margins <sup>p. 11</sup>
| style="text-align:right" | 34%
** '''Beyond 2025 focus''': Capitalizing on attractive growth opportunities and continued cycle management <sup>p. 11</sup>
|-
* '''Earnings growth drivers''':
| style="text-align:left" | AXA XL (Large & Specialty)
** Continued progress on efficiency <sup>p. 11</sup>
| style="text-align:right" | 33%
** Higher investment income <sup>p. 11</sup>
|-
** Data and AI utilization to further enhance customer experience and technical excellence <sup>p. 11</sup>
| style="text-align:left" | SME & Mid-market
| style="text-align:right" | 33%
|}
</div>


=== L&H | Good momentum, well positioned to capture growth opportunities ===
* '''Underlying earnings''' +9% LFL to EUR 5.9bn
* '''AXA XL''' includes AXA XL Re premiums of EUR 2.6bn
* '''Retail and SME & Mid-market''' strategic outlook:
** '''2025''': Growing volumes while expanding margins
** '''Beyond 2025''': Investing to improve customer retention and expanding distribution footprint
* '''AXA XL (Large & Specialty)''' strategic outlook:
** '''2025''': Profitable growth with stable margins
** '''Beyond 2025''': Capitalizing on attractive growth opportunities and continued cycle management
* '''Growth enablers''':
** Continued progress on efficiency
** Higher investment income
** Data & AI to further enhance customer experience and technical excellence
* (pie) '''GWP mix''': EUR 58bn total GWP, split across Retail, AXA XL (Large & Specialty), and SME & Mid-market <sup>p. 11</sup>


* (donut) '''Gross written premiums''' (GWP): EUR 57bn total, split by Short-term and Long-term segments (shares not labeled) <sup>p. 12</sup>
=== L&H| Good momentum, well positioned to capture growth opportunities ===
* '''Underlying earnings''' +7% LFL to EUR 3.5bn <sup>p. 12</sup>

* '''Long-term business''' strategic priorities:
<div style="overflow-x:auto">
{| class="wikitable"
|+ GWP mix <sup>p. 12</sup>
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
|-
| style="text-align:left" | Long-term
| class="col-s" style="text-align:right" | Majority
|-
| style="text-align:left" | Short-term
| class="col-s" style="text-align:right" | Minority
|}
</div>

* Underlying earnings +7% LFL to EUR 3.5bn <sup>p. 12</sup>
* '''Long-term business''' strategic outlook:
** '''2025''': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>
** '''2025''': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>
** '''Beyond 2025''': Capturing savings & retirement opportunity, sourcing best asset management products for our customers <sup>p. 12</sup>
** '''Beyond 2025''': Capturing savings & retirement opportunity, sourcing best asset management products for our customers <sup>p. 12</sup>
* '''Short-term business''' strategic outlook:
* '''Short-term business''' strategic priorities:
** '''2025''': Growing technical results while absorbing Mexico VAT impact <sup>p. 12</sup>
** '''2025''': Growing technical results while absorbing Mexico VAT impact <sup>p. 12</sup>
** '''Beyond 2025''': Capitalizing on demand for health & protection while further improving our margins <sup>p. 12</sup>
** '''Beyond 2025''': Capitalizing on demand for health & protection while further improving our margins <sup>p. 12</sup>
Line 246: Line 201:
** Increasing penetration of Protection riders in Savings offerings <sup>p. 12</sup>
** Increasing penetration of Protection riders in Savings offerings <sup>p. 12</sup>
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>
* (pie) '''GWP mix''': EUR 57bn total, split between Long-term (majority) and Short-term <sup>p. 12</sup>


=== FY25 Financial Performance ===
== FY25 Financial Performance ==


* '''Section 3''': FY25 Financial Performance presented by Alban de Mailly Nesle, Group CFO <sup>p. 13</sup>
* '''Section 3''': FY25 Financial Performance presented by Alban de Mailly Nesle, Group CFO <sup>p. 13</sup>


=== P&C| Continued disciplined growth ===
=== P&C | Continued disciplined growth ===


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| class="wikitable fintable"
{| class="wikitable fintable"
|+ GWP & other revenues by segment <sup>p. 14</sup>
|+ GWP & other revenues by segment, FY24 vs FY25 <sup>p. 14</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY24
Line 285: Line 239:
| style="text-align:right" | +2%
| style="text-align:right" | +2%
|-
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:left; font-weight:bold" | Total GWP & other revenues
| style="text-align:right; font-weight:bold" | 56.5
| style="text-align:right; font-weight:bold" | 56.5
| style="text-align:right; font-weight:bold" | 58.0
| style="text-align:right; font-weight:bold" | 58.0
Line 293: Line 247:
|}
|}
</div>
</div>

* Continued pricing momentum and volume growth in Mid-market and SME <sup>p. 14</sup>.
* Continued pricing momentum and volume growth in Mid-market and SME <sup>p. 14</sup>.
* Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance <sup>p. 14</sup>.
* Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance <sup>p. 14</sup>.
Line 299: Line 252:
* Favorable pricing trends and strong growth in net new contracts with +1.7m in FY25 <sup>p. 14</sup>.
* Favorable pricing trends and strong growth in net new contracts with +1.7m in FY25 <sup>p. 14</sup>.


=== P&C| Delivering further margin expansion while enhancing reserve prudence ===
=== P&C | Delivering further margin expansion while enhancing reserve prudence ===


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| class="wikitable fintable"
{| class="wikitable fintable"
|+ Combined ratio components <sup>p. 15</sup>
|+ Combined ratio components, FY24 vs FY25 <sup>p. 15</sup>
! style="text-align:left" | %
! style="text-align:left" | Combined ratio
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY25
|-
|-
| style="text-align:left" | Undiscounted CY loss ratio (ex Nat Cat)
| style="text-align:left" | Undiscounted CY loss ratio (ex Nat Cat)
| style="text-align:right" | 67.4
| style="text-align:right" | 67.4%
| style="text-align:right" | 67.0
| style="text-align:right" | 67.0%
|-
|-
| style="text-align:left" | Expense ratio
| style="text-align:left" | Expense ratio
| style="text-align:right" | 25.0
| style="text-align:right" | 25.0%
| style="text-align:right" | 24.8
| style="text-align:right" | 24.8%
|-
|-
| style="text-align:left" | Nat Cat
| style="text-align:left" | Nat Cat
| style="text-align:right" | 3.8
| style="text-align:right" | 3.8%
| style="text-align:right" | 3.4
| style="text-align:right" | 3.4%
|-
|-
| style="text-align:left" | Prior year reserve development
| style="text-align:left" | Prior year reserve development
| style="text-align:right" | -1.6
| style="text-align:right" | -1.6%
| style="text-align:right" | -1.1
| style="text-align:right" | -1.1%
|-
|-
| style="text-align:left" | Discount
| style="text-align:left" | Discount
| style="text-align:right" | -3.6
| style="text-align:right" | -3.6%
| style="text-align:right" | -3.5
| style="text-align:right" | -3.5%
|-
| style="text-align:left; font-weight:bold" | Total combined ratio
| style="text-align:right; font-weight:bold" | 91.0%
| style="text-align:right; font-weight:bold" | 90.6%
|}
|}
</div>
</div>
* Undiscounted CY loss ratio (ex Nat Cat) improved from:

** Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting a favorable pricing environment <sup>p. 15</sup>
* Combined ratio improved to 90.6% (prior: 91.0%) <sup>p. 15</sup>
* '''Undiscounted CY loss ratio''' excluding Nat Cat improved from:
** Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting favorable pricing environment <sup>p. 15</sup>
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management <sup>p. 15</sup>
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management <sup>p. 15</sup>
* '''Expense ratio''' improved reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology <sup>p. 15</sup>
* Expense ratio improved reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology <sup>p. 15</sup>
* '''Nat Cat charges''' below normalized load <sup>p. 15</sup>
* Nat Cat charges were below the normalized load <sup>p. 15</sup>
* '''Prior year reserve development''' reliance was lower, taking advantage of a good year to enhance reserve prudence <sup>p. 15</sup>
* Prior year reserve development showed lower reliance, taking advantage of a good year to enhance reserve prudence <sup>p. 15</sup>


=== P&C| Earnings growth from higher underwriting and financial result ===
=== P&C | Earnings growth from higher underwriting and financial result ===


<div style="overflow-x:auto">
<div style="overflow-x:auto">
Line 349: Line 304:
| style="text-align:right" | 5,510
| style="text-align:right" | 5,510
|-
|-
| style="text-align:left" | Volume growth
| style="text-align:left" | Underwriting result¹ (volume growth)
| style="text-align:right" | +292
| style="text-align:right" | +292
|-
|-
| style="text-align:left" | Margin improvement
| style="text-align:left" | Underwriting result¹ (margin improvement)
| style="text-align:right" | +189
| style="text-align:right" | +189
|-
|-
| style="text-align:left" | Investment income
| style="text-align:left" | Financial result (investment income)
| style="text-align:right" | +435
| style="text-align:right" | +435
|-
|-
| style="text-align:left" | Insurance finance expenses
| style="text-align:left" | Financial result (insurance finance expenses)
| style="text-align:right" | -235
| style="text-align:right" | -235
|-
|-
Line 371: Line 326:
|}
|}
</div>
</div>
* Underlying earnings grew +9% at constant FX to EUR 5,872m <sup>p. 16</sup>.

* Underwriting result improved from strong volume growth and improved all-year combined ratio while enhancing reserve prudence <sup>p. 16</sup>.
* '''Underlying earnings''' grew +9% at constant FX to EUR 5,872m.
* Investment income increased reflecting higher volumes and better reinvestment yields on fixed income assets <sup>p. 16</sup>.
* '''Underwriting result''' improved from strong volume growth and improved all-year combined ratio while enhancing reserve prudence.
* '''Investment income''' increased reflecting higher volumes and better reinvestment yields on fixed income assets.
* Insurance finance expenses increased from higher unwind of discount of claims reserves, in line with guidance <sup>p. 16</sup>.
* Forex impact was unfavorable, notably due to USD depreciation vs. EUR <sup>p. 16</sup>.
* '''Insurance finance expenses''' impacted by higher unwind of discount of claims reserves, in line with guidance.
* '''Forex impact''' was unfavorable, notably due to USD depreciation vs. EUR.


=== Life & Health | Strong growth in premiums, positive net flows ===
=== Life & Health | Strong growth in premiums, positive net flows ===
Line 382: Line 336:
<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| class="wikitable fintable"
{| class="wikitable fintable"
|+ Life GWP & other revenues, FY24 vs FY25 <sup>p. 17</sup>
|+ GWP & Other Revenues and Net Flows by segment, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL change
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | '''Life GWP & Other Revenues'''
| style="text-align:right" | 34.5
| style="text-align:right" | 37.5
| style="text-align:right" | +9%
|-
|-
| style="text-align:left" | Protection
| style="text-align:left" | Protection
Line 408: Line 367:
| style="text-align:right" | -7%
| style="text-align:right" | -7%
|-
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:left" | '''Health GWP & Other Revenues'''
| style="text-align:right; font-weight:bold" | 34.5
| style="text-align:right" | 17.5
| style="text-align:right; font-weight:bold" | 37.5
| style="text-align:right" | 19.0
| style="text-align:right; font-weight:bold" | +9%
| style="text-align:right" | +5%
|}
</div>

<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Health GWP & other revenues, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL change
|-
|-
| style="text-align:left" | Individual
| style="text-align:left" | Individual
Line 433: Line 382:
| style="text-align:right" | +4%
| style="text-align:right" | +4%
|-
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:left" | '''Employee Benefits GWP & Other Revenues'''
| style="text-align:right; font-weight:bold" | 17.5
| style="text-align:right" |
| style="text-align:right; font-weight:bold" | 19.0
| style="text-align:right" | 12.9
| style="text-align:right; font-weight:bold" | +5%
| style="text-align:right" | +4%
|}
|-
| style="text-align:left" | '''Net flows'''
</div>
| style="text-align:right" | 1.5

<div style="overflow-x:auto">
| style="text-align:right" | 5.4
| style="text-align:right" | —
{| class="wikitable fintable"
|+ Net flows by segment, FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Net flows
|-
|-
| style="text-align:left" | Protection
| style="text-align:left" | Protection
| style="text-align:right" | +4.9
| style="text-align:right" |
| style="text-align:right" | 4.9
| style="text-align:right" | —
|-
|-
| style="text-align:left" | Health
| style="text-align:left" | Health
| style="text-align:right" | +2.7
| style="text-align:right" |
| style="text-align:right" | 2.7
| style="text-align:right" | —
|-
|-
| style="text-align:left" | Unit-linked
| style="text-align:left" | Unit-Linked
| style="text-align:right" | +1.5
| style="text-align:right" |
| style="text-align:right" | 1.5
| style="text-align:right" | —
|-
|-
| style="text-align:left" | Capital light G/A
| style="text-align:left" | Capital light G/A
| style="text-align:right" | +1.2
| style="text-align:right" |
| style="text-align:right" | 1.2
| style="text-align:right" | —
|-
|-
| style="text-align:left" | Traditional G/A
| style="text-align:left" | Traditional G/A
| style="text-align:right" | —
| style="text-align:right" | -5.0
| style="text-align:right" | -5.0
| style="text-align:right" | —
|}
|}
</div>
</div>

* '''Employee Benefits''' GWP and other revenues (including both short-term and long-term) was EUR 12.9bn in FY25, up +4%.
* '''Net flows''' reached EUR +5.4bn (compared to EUR +1.5bn in FY24).


=== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ===
=== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ===
Line 470: Line 423:
<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| class="wikitable fintable"
{| class="wikitable fintable"
|+ PVEP, NB CSM, and NBV, FY24 vs FY25 <sup>p. 18</sup>
|+ PVEP, NB CSM, NBV, and NBV margin, FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL change
! class="col-s" style="text-align:right" | LFL Change
|-
|-
| style="text-align:left" | '''PVEP'''
| style="text-align:left" | '''PVEP'''
Line 511: Line 464:
| style="text-align:right" | stable
| style="text-align:right" | stable
|-
|-
| style="text-align:left" | NBV margin
| style="text-align:left" | '''NBV margin'''
| style="text-align:right" | 4.4%
| style="text-align:right" | 4.4%
| style="text-align:right" | 4.5%
| style="text-align:right" | 4.5%
Line 518: Line 471:
</div>
</div>


* '''PVEP''' was impacted by higher interest rates on discounting despite strong growth in Life volumes.
* PVEP impacted by higher interest rates on discounting despite strong growth in Life volumes.
* '''NB CSM''' was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits.
* NB CSM driven by robust Savings & Protection sales; reported growth impacted by higher interest rates for discounting of future profits.
* '''NBV''' was stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France.
* NBV broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France.


=== Life & Health | Growth in new business driving Normalized CSM growth ===
=== Life & Health | Growth in new business driving Normalized CSM growth ===
Line 530: Line 483:
! class="col-s" style="text-align:right" | Contractual Service Margin
! class="col-s" style="text-align:right" | Contractual Service Margin
|-
|-
| style="text-align:left" | FY24 starting value
| style="text-align:left" | FY24
| style="text-align:right" | 33.6
| style="text-align:right" | 33.6
|-
|-
Line 551: Line 504:
| style="text-align:right" | -1.4
| style="text-align:right" | -1.4
|-
|-
| style="text-align:left" | FY25 ending value
| style="text-align:left" | FY25
| style="text-align:right" | 33.0
| style="text-align:right" | 33.0
|}
|}
</div>
</div>


* '''Normalized CSM''' up by +2% LFL, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates.
* Normalized CSM up by +2% LFL, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates.
* '''Economic variance''' reflecting government spreads tightening and positive equity market returns.
* Economic variance reflecting government spreads tightening and positive equity market returns.
* '''Operating variance''' driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland.
* Operating variance driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland.
* '''FX impact''' mainly from JPY and HKD depreciation.
* FX impact mainly from JPY and HKD depreciation.
* Normalized CSM growth +2% (comprising New business CSM, Underlying return on in-force, and CSM release).
* FY24 starting value: o/w Life EUR 25.8bn, o/w Health EUR 7.7bn
* FY24 Life segment share: EUR 25.8bn
* CSM release: Normalized CSM growth +2%
* FY24 Health segment share: EUR 7.7bn
* FY25 ending value: o/w Life EUR 25.4bn, o/w Health EUR 7.6bn
* FY25 Life segment share: EUR 25.4bn
* FY25 Health segment share: EUR 7.6bn


=== Life & Health | Strong momentum in both short-term and long-term business ===
=== Life & Health | Strong momentum in both short-term and long-term business ===
Line 572: Line 527:
! class="col-s" style="text-align:right" | Underlying earnings
! class="col-s" style="text-align:right" | Underlying earnings
|-
|-
| style="text-align:left" | FY24 start
| style="text-align:left" | FY24
| style="text-align:right" | 3,323
| style="text-align:right" | 3,323
|-
|-
Line 587: Line 542:
| style="text-align:right" | -27
| style="text-align:right" | -27
|-
|-
| style="text-align:left" | FY25 end
| style="text-align:left" | FY25
| style="text-align:right" | 3,501
| style="text-align:right" | 3,501
|}
|}
</div>
</div>


* '''Underlying earnings''' +7% LFL to EUR 3,501m (reported: EUR 3,323m in FY24)
* '''Underlying earnings''' +7% LFL to EUR 3,501m <sup>p. 20</sup>
* '''Short-term technical margin''': EUR 415m in FY24 to EUR 479m in FY25
* '''Short-term technical margin''': EUR 415m in FY24 to EUR 479m in FY25 <sup>p. 20</sup>
* '''Long-term result''' incl. CSM release: EUR 2,680m in FY24 to EUR 2,804m in FY25
* '''Long-term result''' incl. CSM release: EUR 2,680m in FY24 to EUR 2,804m in FY25 <sup>p. 20</sup>
* '''Financial result''': EUR 975m in FY24 to EUR 946m in FY25
* '''Financial result''': EUR 975m in FY24 to EUR 946m in FY25 <sup>p. 20</sup>
* '''Tax & others''': EUR -748m in FY24 to EUR -728m in FY25
* '''Tax & others''': EUR -748m in FY24 to EUR -728m in FY25 <sup>p. 20</sup>
* '''Life segment''' contribution: EUR 2.6bn in FY24 to EUR 2.7bn in FY25 (+4% vs. FY24)
* '''Life underlying earnings''' (o/w Life) grew to EUR 2.7bn (+4% vs. FY24; FY24 was EUR 2.6bn) <sup>p. 20</sup>
* '''Health segment''' contribution: EUR 0.7bn in FY24 to EUR 0.8bn in FY25 (+17% vs. FY24)
* '''Health underlying earnings''' (o/w Health) grew to EUR 0.8bn (+17% vs. FY24; FY24 was EUR 0.7bn) <sup>p. 20</sup>
* '''Short-term technical margin''' strong on underwriting and claims initiatives; more than offset legislative change on Mexico VAT recoverability of EUR -0.1bn
* '''Short-term technical margin''' strong, reflecting underwriting and claims initiatives that more than offset the impact of legislative change on the recoverability of value added tax in Mexico of EUR -0.1bn <sup>p. 20</sup>
* '''Long-term results''' higher from CSM release increase of +8% on reserve base growth, favorable equity markets, and better margins
* '''Long-term results''' higher from increase in CSM release (+8%) reflecting growth in reserve base, including from favorable equity market performance, and better margins <sup>p. 20</sup>


=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===

* '''Underlying earnings''' driven by strong performance from insurance businesses <sup>p. 21</sup>
* '''Holding cost''' stable, expected to remain at current level in 2026 <sup>p. 21</sup>
* '''Net income''' increase mainly reflects higher underlying earnings and the gain from the sale of AXA IM <sup>p. 21</sup>
* '''Financial flows''' lower, reflecting unfavorable forex impact <sup>p. 21</sup>


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| class="wikitable fintable"
{| class="wikitable fintable"
|+ Earnings and income metrics <sup>p. 21</sup>
|+ Earnings and net income bridge FY24 to FY25 (in EUR billion) <sup>p. 21</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! style="text-align:left" |
! class="col-s" style="text-align:right" | Prior year
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | Current year
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change at constant FX
! class="col-s" style="text-align:right" | Change
|-
|-
| style="text-align:left" | Property & Casualty
| style="text-align:left" | Property & Casualty
Line 630: Line 590:
| style="text-align:right" | -1.2
| style="text-align:right" | -1.2
| style="text-align:right" | -1.2
| style="text-align:right" | -1.2
| style="text-align:right" | flat
| style="text-align:right" | -
|-
|-
| style="text-align:left" | Underlying earnings
| style="text-align:left" | '''Underlying earnings'''
| style="text-align:right" | 8.1
| style="text-align:right" | '''8.1'''
| style="text-align:right" | 8.4
| style="text-align:right" | '''8.4'''
| style="text-align:right" | +6%
| style="text-align:right" | '''+6%'''
|-
|-
| style="text-align:left" | Non-financial flows
| style="text-align:left" | Non-financial flows
Line 642: Line 602:
| style="text-align:right" | —
| style="text-align:right" | —
|-
|-
| style="text-align:left" | Financial flows (including RCG)
| style="text-align:left" | ''o/w capital gains from AXA IM disposal''
| style="text-align:right" | -
| style="text-align:right" | +2.2
| style="text-align:right" | —
|-
| style="text-align:left" | Financial flows (incl. RCG)
| style="text-align:right" | +0.3
| style="text-align:right" | +0.3
| style="text-align:right" | -0.7
| style="text-align:right" | -0.7
| style="text-align:right" | —
| style="text-align:right" | —
|-
|-
| style="text-align:left" | Net income
| style="text-align:left" | '''Net income'''
| style="text-align:right" | 7.9
| style="text-align:right" | '''7.9'''
| style="text-align:right" | 9.8
| style="text-align:right" | '''9.8'''
| style="text-align:right" | +26%
| style="text-align:right" | '''+26%'''
|}
|}
</div>
</div>


* (bar) '''Underlying earnings per share''' (in EUR): FY24 EUR 3.59 → FY25 EUR 3.86 (+8%) <sup>p. 21</sup>
<div style="overflow-x:auto">
** '''Earnings growth''' contributed +6% <sup>p. 21</sup>
{| class="wikitable fintable"
|+ Underlying earnings per share (reported basis) <sup>p. 21</sup>
** '''Capital management''' contributed +3% <sup>p. 21</sup>
** '''Forex''' contributed -2% <sup>p. 21</sup>
! style="text-align:left" | EUR
** '''AXA IM sale''' included -1% from temporary earnings dilution due to the timing of anti-dilutive share buyback <sup>p. 21</sup>
! class="col-s" style="text-align:right" | Value
|-
| style="text-align:left" | Prior year
| style="text-align:right" | 3.59
|-
| style="text-align:left" | Current year
| style="text-align:right" | 3.86
|-
| style="text-align:left" | Change
| style="text-align:right" | +8%
|-
| style="text-align:left" | Earnings growth contribution
| style="text-align:right" | +6%
|-
| style="text-align:left" | Capital management contribution
| style="text-align:right" | +3%
|-
| style="text-align:left" | Forex impact
| style="text-align:right" | -2%
|-
| style="text-align:left" | Dilution impact
| style="text-align:right" | -1%
|}
</div>

* '''Underlying earnings''' driven by strong performance from insurance businesses
* '''Holdings & other''' cost stable, expected to remain at current level in 2026
* '''Net income''' increase mainly reflects higher underlying earnings and the gain from the sale of AXA IM
* '''Non-financial flows''': Capital gains from AXA IM disposal: EUR +2.2bn (prior: nil)
* '''Financial flows''' lower, reflecting unfavorable forex impact
* '''Dilution''' impact: includes -1% from temporary earnings dilution from AXA IM sale due to the timing of the anti-dilutive share buyback

== FY25 Financial Performance ==


=== Shareholders' Equity ===
=== Shareholders' Equity ===
Line 696: Line 629:
<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| class="wikitable fintable"
{| class="wikitable fintable"
|+ Shareholders' equity and related metrics <sup>p. 22</sup>
|+ Shareholders' equity (Group share) and other metrics <sup>p. 22</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY24
Line 702: Line 635:
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY25
|-
|-
| style="text-align:left" | Shareholders' equity total
| style="text-align:left" | Shareholders' equity (total)
| style="text-align:right" | 49.9
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
| style="text-align:right" | 45.5
| style="text-align:right" | 47.2
| style="text-align:right" | 47.2
|-
|-
| style="text-align:left" | SHE excl. OCI
| style="text-align:left" | SHE (excl. OCI)
| style="text-align:right" | 58.0
| style="text-align:right" | 58.0
| style="text-align:right" | 52.7
| style="text-align:right" | 52.7
Line 736: Line 669:
<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| class="wikitable fintable"
{| class="wikitable fintable"
|+ Shareholders' equity bridge, FY24 to FY25 vs. HY25 to FY25 <sup>p. 22</sup>
|+ Shareholders' equity roll-forward (in Euro billion) <sup>p. 22</sup>
! style="text-align:left" | EUR billion
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24 to FY25
! class="col-s" style="text-align:right" | FY24 to FY25
! class="col-s" style="text-align:right" | HY25 to FY25
! class="col-s" style="text-align:right" | HY25 to FY25
|-
|-
| style="text-align:left" | Opening Shareholders' equity
| style="text-align:left" | '''Opening Shareholders' equity'''
| style="text-align:right" | 49.9
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
| style="text-align:right" | 45.5
|-
|-
| style="text-align:left" | Change in Net OCI
| style="text-align:left" | Change in Net OCI
| style="text-align:right" | +1.3
| style="text-align:right" | 1.3
| style="text-align:right" | +0.4
| style="text-align:right" | 0.4
|-
|-
| style="text-align:left" | Net income for the period
| style="text-align:left" | Net income for the period
| style="text-align:right" | +9.8
| style="text-align:right" | 9.8
| style="text-align:right" | +5.9
| style="text-align:right" | 5.9
|-
|-
| style="text-align:left" | Dividend
| style="text-align:left" | Dividend
| style="text-align:right" | -4.6
| style="text-align:right" | -4.6
| style="text-align:right" | nil
| style="text-align:right" | -
|-
|-
| style="text-align:left" | Annual share buyback
| style="text-align:left" | Annual share buyback
| style="text-align:right" | -1.2
| style="text-align:right" | -1.2
| style="text-align:right" | nil
| style="text-align:right" | -
|-
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
Line 775: Line 708:
| style="text-align:left" | Other
| style="text-align:left" | Other
| style="text-align:right" | -0.6
| style="text-align:right" | -0.6
| style="text-align:right" | +0.3
| style="text-align:right" | 0.3
|-
|-
| style="text-align:left" | Closing Shareholders' equity
| style="text-align:left" | '''Closing Shareholders' equity'''
| style="text-align:right" | 47.2
| style="text-align:right" | 47.2
| style="text-align:right" | 47.2
| style="text-align:right" | 47.2
|}
|}
</div>
</div>

* '''Shareholders' equity''' (Group share) reported in EUR billion <sup>p. 22</sup>.
* '''Reporting currency''' is in Euro billion <sup>p. 22</sup>.


=== Higher organic cash remittance and robust cash position at Holding ===
=== Higher organic cash remittance and robust cash position at Holding ===


* '''Net cash remittance''' increased to EUR 7.5bn in FY25 <sup>p. 23</sup>
<div style="overflow-x:auto">
** (bar) '''Net cash remittance trend''': FY24 EUR 7.7bn (comprising EUR 7.1bn ordinary remittance and EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe) → FY25 EUR 7.5bn <sup>p. 23</sup>
{| class="wikitable fintable"
|+ Net cash remittance and Holding cash position bridge <sup>p. 23</sup>
** '''Remittance ratio''' remained stable at 82% in FY24 and 82% in FY25, based on ordinary cash remittance of EUR 7.1bn in FY24 and EUR 7.5bn in FY25 <sup>p. 23</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Net cash remittance total
| style="text-align:right" | 7.7
| style="text-align:right" | 7.5
|-
| style="text-align:left" | Ordinary remittance
| style="text-align:right" | 7.1
| style="text-align:right" | 7.5
|-
| style="text-align:left" | Proceeds related to in-force treaties
| style="text-align:right" | 0.6
| style="text-align:right" | —
|-
| style="text-align:left" | Remittance ratio
| style="text-align:right" | 82%
| style="text-align:right" | 82%
|}
</div>


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| class="wikitable fintable"
{| class="wikitable fintable"
|+ Holding cash position bridge <sup>p. 23</sup>
|+ Holding cash position bridge FY24 to FY25 (in Euro billion) <sup>p. 23</sup>
! style="text-align:left" | EUR billion
! style="text-align:left" | FY24 Cash position
! class="col-s" style="text-align:right" | Value
! class="col-s" style="text-align:right" | 4.0
|-
| style="text-align:left" | FY24 Cash position
| style="text-align:right" | 4.0
|-
|-
| style="text-align:left" | Net cash remittance from subsidiaries
| style="text-align:left" | Net cash remittance from subsidiaries
Line 845: Line 755:
|}
|}
</div>
</div>

* Proceeds related to in-force treaties of EUR 0.6bn in FY24 related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe <sup>p. 23</sup>


=== Solvency II at 224% ===
=== Solvency II at 224% ===
Line 854: Line 762:
|+ Solvency II walk, FY24 to FY25 <sup>p. 24</sup>
|+ Solvency II walk, FY24 to FY25 <sup>p. 24</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | Eligible Own Funds (EOF)
! class="col-s" style="text-align:right" | Eligible Own Funds
! class="col-s" style="text-align:right" | Solvency Capital Requirement (SCR)
! class="col-s" style="text-align:right" | Solvency Capital Requirement
! class="col-s" style="text-align:right" | Solvency II ratio (pts)
! class="col-s" style="text-align:right" | Solvency II ratio (pts)
|-
|-
Line 902: Line 810:
<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| class="wikitable fintable"
{| class="wikitable fintable"
|+ Key sensitivities of Solvency II ratio as of December 31, 2025 (Base: 224%) <sup>p. 24</sup>
|+ Solvency II sensitivities as of December 31, 2025 (base ratio 224%) <sup>p. 24</sup>
! style="text-align:left" | Sensitivity
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | Change (pts)
! class="col-s" style="text-align:right" | pts
|-
|-
| style="text-align:left" | Interest rate +50bps
| style="text-align:left" | Interest rate +50bps
Line 938: Line 846:
</div>
</div>


* '''Solvency II ratio''' increased to 224% in FY25 (was 216% in FY24) <sup>p. 24</sup>.
* Dividend & annual share buyback includes foreseeable dividends of -EUR 4.8bn and provision for annual share buyback for 2026 of -EUR 1.25bn <sup>p. 24</sup>.
* '''Foreseeable dividends''' were EUR -4.8bn <sup>p. 24</sup>.
* '''Provision for share buyback''' for 2026 was EUR -1.25bn <sup>p. 24</sup>.
* Euro Sovereign spreads +50bps: (assumes 50bps spread widening of Euro sovereign bonds vs. Euro swap curve applied on sovereign and quasi-sovereign exposures) <sup>p. 24</sup>
* Credit migration: (assumes 20% of corporate bonds, including private debt, held are downgraded by one full letter / 3 notches) <sup>p. 24</sup>


=== Solvency II -impact of the end of grandfathering period and Solvency II revision ===
=== Solvency II -impact of the end of grandfathering period and Solvency II revision ===
Line 944: Line 856:
<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| class="wikitable fintable"
{| class="wikitable fintable"
|+ Solvency II ratio and impacts <sup>p. 25</sup>
|+ Solvency II ratio evolution <sup>p. 25</sup>
! style="text-align:left" | Solvency II ratio (pts)
! style="text-align:left" | Solvency II ratio
! class="col-s" style="text-align:right" | Value
! class="col-m" style="text-align:right" | Value
|-
|-
| style="text-align:left" | As of December 31, 2025
| style="text-align:left" | As of December 31, 2025
| style="text-align:right" | 224
| style="text-align:right" | 224%
|-
|-
| style="text-align:left" | Grandfathering end impact on January 1, 2026
| style="text-align:left" | Grandfathering end impact on January 1, 2026
| style="text-align:right" | -10
| style="text-align:right" | -10pts to 215%
|-
|-
| style="text-align:left" | Ratio after grandfathering impact
| style="text-align:left" | Solvency II revision impact to come into effect in 1Q27
| style="text-align:right" | 215
| style="text-align:right" | +17pts
|-
| style="text-align:left" | Solvency II revision impact (estimated)
| style="text-align:right" | +17
|}
|}
</div>
</div>
* EUR 2.4bn of grandfathered debt is no longer eligible as capital from January 1, 2026.
* EUR 2.4bn grandfathered debt is no longer eligible as capital from January 1, 2026 <sup>p. 25</sup>.
* Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date <sup>p. 25</sup>.
* No change is expected in organic capital generation.
* No change is expected in organic capital generation <sup>p. 25</sup>.
* Provides additional capital flexibility.
* Provides additional capital flexibility <sup>p. 25</sup>.
* Revision impact is estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.
* '''Solvency II revision''' impact, expected to come into effect in 1Q27, is estimated at +17pts <sup>p. 25</sup>.


=== Thomas Buberl, Group CEO Conclusion ===
=== Thomas Buberl, Group CEO conclusion ===


* '''Section divider''' for the conclusion presentation by Thomas Buberl, Group CEO <sup>p. 26</sup>.
* '''Conclusion''' presented by Thomas Buberl, Group CEO <sup>p. 26</sup>


=== Conclusion ===
=== Conclusion ===


* '''Record results''' achieved at the top end of the target range while enhancing reserve prudence <sup>p. 27</sup>.
* '''Record results''' achieved at the top end of the target range while enhancing reserve prudence <sup>p. 27</sup>.
* '''All businesses''' in excellent shape, delivering strong growth and profitability <sup>p. 27</sup>.
* '''Business performance''' shows all businesses in excellent shape, delivering strong growth and profitability <sup>p. 27</sup>.
* '''Diversified franchise''' well-positioned to capture future growth opportunities <sup>p. 27</sup>.
* '''Diversified franchise''' is well-positioned to capture future growth opportunities <sup>p. 27</sup>.
* '''Future outlook''' focused on laying foundations for the next plan and confident in delivering sustainable earnings growth <sup>p. 27</sup>.
* '''Strategic outlook''' focused on laying foundations for the next plan and confident in delivering sustainable earnings growth <sup>p. 27</sup>.


=== February 26, 2026 Q&A Full Year 2025 Earnings ===
=== February 26, 2026 Q&A Full Year 2025 earnings ===


* '''Q&A session''' for Full Year 2025 Earnings held on February 26, 2026 <sup>p. 28</sup>
* '''Session title''': Q&A Full Year 2025 Earnings, February 26, 2026 <sup>p. 28</sup>


=== AXA Investor Relations | Keep in touch ===
=== AXA Investor Relations | Keep in touch ===


* '''Roadshows''': March in Europe and US <sup>p. 29</sup>
* '''Investor Relations contact''' details: phone +33 1 40 75 48 42, email investor.relations@axa.com <sup>p. 29</sup>
* '''1Q25 Activity Indicators''': May 5 in Paris <sup>p. 29</sup>
* '''Follow us''' on www.axa.com and social media channels <sup>p. 29</sup>

* '''BNP Paribas Exane''' CEO Conference: June 2 in Paris <sup>p. 29</sup>
<div style="overflow-x:auto">
* '''Goldman Sachs European''' Financials Conference: June 2-4 in Zurich <sup>p. 29</sup>
{| class="wikitable"
* '''HY26 Earnings Release''': July 31 in Paris <sup>p. 29</sup>
* '''AXA Investor Day''': September 21 in London <sup>p. 29</sup>
|+ Meet our management event schedule <sup>p. 29</sup>
! style="text-align:left" | Date
* '''Investor Relations contact''': +33 1 40 75 48 42; investor.relations@axa.com <sup>p. 29</sup>
! class="col-m" style="text-align:right" | Event
* '''Follow us''': www.axa.com <sup>p. 29</sup>
! class="col-m" style="text-align:right" | Location
|-
| style="text-align:left" | March
| class="col-m" style="text-align:right" | Roadshows
| class="col-m" style="text-align:right" | Europe and US
|-
| style="text-align:left" | May 5
| class="col-m" style="text-align:right" | 1Q25 Activity Indicators
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | June 2
| class="col-m" style="text-align:right" | BNP Paribas Exane CEO Conference
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | June 2-4
| class="col-m" style="text-align:right" | Goldman Sachs European Financials Conference
| class="col-m" style="text-align:right" | Zurich
|-
| style="text-align:left" | July 31
| class="col-m" style="text-align:right" | HY26 Earnings Release
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | September 21
| class="col-m" style="text-align:right" | AXA Investor Day
| class="col-m" style="text-align:right" | London
|}
</div>


== Appendices ==
== Appendices ==


* Section divider slide marking the beginning of the '''Appendices''' section <sup>p. 30</sup>.
* Section divider slide for '''Appendices''' <sup>p. 30</sup>.


=== Table of contents ===
=== Table of contents ===


* '''Table of contents''' agenda structure:
* '''Debt and Invested Assets''' <sup>p. 31</sup>
** 1. '''Debt and Invested Assets''' <sup>p. 31</sup>
* '''Additional P&C disclosures''' <sup>p. 36</sup>
** 2. Additional P&C disclosures <sup>p. 36</sup>
* '''Additional IFRS17 disclosures''' <sup>p. 41</sup>
** 3. Additional IFRS17 disclosures <sup>p. 41</sup>
* '''Sustainability''' <sup>p. 44</sup>
** 4. Sustainability <sup>p. 44</sup>


=== Gross financial debt and maturity breakdown as of December 31 st , 2025 ===
=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===


* '''Debt gearing''' was 20.6% in FY24 and 22.3% in FY25 <sup>p. 32</sup>.
* (stacked bar) '''Gross financial debt''' (nominal basis):
* (stacked bar) '''Gross financial debt''' (nominal debt):
** '''FY24''': EUR 19.2bn total (Tier 1: EUR 4.8bn; Tier 2: EUR 10.8bn; Senior debt: EUR 3.5bn) <sup>p. 32</sup>
** '''FY25''': EUR 20.3bn total (Tier 1: EUR 4.6bn; Tier 2: EUR 12.2bn; Senior debt: EUR 3.5bn) <sup>p. 32</sup>
** '''FY24''': EUR 19.2bn total; Tier 1 EUR 4.8bn, Tier 2 EUR 10.8bn, Senior debt EUR 3.5bn <sup>p. 32</sup>
** '''Jan 1st 2026''' (End of the grandfathering period): EUR 20.3bn total (Tier 1: EUR 3.2bn; Tier 2: EUR 11.3bn; Senior debt: EUR 5.8bn, of which EUR 0.4bn redeemed in Jan 2026) <sup>p. 32</sup>
** '''FY25''': EUR 20.3bn total; Tier 1 EUR 4.6bn, Tier 2 EUR 12.2bn, Senior debt EUR 3.5bn <sup>p. 32</sup>
* '''Debt gearing''': 20.6% in FY24 to 22.3% in FY25 <sup>p. 32</sup>
** '''Jan 1st 2026''' (End of the grandfathering period): EUR 20.3bn total; Tier 1 EUR 3.2bn, Tier 2 EUR 11.3bn, Senior debt EUR 5.8bn (of which EUR 0.4bn redeemed in Jan 2026) <sup>p. 32</sup>
* (stacked bar) '''Contractual maturity breakdown''':
* (stacked bar) '''Contractual maturity breakdown''':
** '''2028''': EUR 0.5bn (Senior debt) <sup>p. 32</sup>
** '''2028''': Senior debt EUR 0.5bn <sup>p. 32</sup>
** '''2030''': EUR 0.9bn total (Tier 2: EUR 0.7bn; Senior debt: EUR 0.2bn) <sup>p. 32</sup>
** '''2030''': Tier 2 EUR 0.7bn, Senior debt EUR 0.9bn <sup>p. 32</sup>
*** '''o/w Grandfathered debt''': Tier 2: EUR 0.7bn <sup>p. 32</sup>
** '''2031-2039''': Senior debt EUR 1.5bn <sup>p. 32</sup>
** '''2031-2039''': EUR 1.5bn (Senior debt) <sup>p. 32</sup>
** '''>=2040''': Tier 2 EUR 10.8bn, Senior debt EUR 0.5bn <sup>p. 32</sup>
** '''≥2040''': EUR 11.3bn total (Tier 2: EUR 10.8bn; Senior debt: EUR 0.5bn) <sup>p. 32</sup>
** '''Undated''': Tier 1 EUR 4.6bn, Tier 2 EUR 0.7bn <sup>p. 32</sup>
*** '''o/w Grandfathered debt''': Tier 2: EUR 0.2bn <sup>p. 32</sup>
** '''Of which grandfathered debt''':
** '''Undated''': EUR 5.3bn total (Tier 1: EUR 4.6bn; Tier 2: EUR 0.7bn) <sup>p. 32</sup>
*** '''Tier 1''': Undated EUR 1.4bn <sup>p. 32</sup>
*** '''o/w Grandfathered debt''': Tier 1: EUR 1.4bn <sup>p. 32</sup>
*** '''Tier 2''': 2030 EUR 0.7bn, >=2040 EUR 0.2bn <sup>p. 32</sup>
* (stacked bar) '''Economic maturity breakdown''':
* (stacked bar) '''Economic maturity breakdown''':
** '''2026''': EUR 0.1bn (Tier 1) <sup>p. 32</sup>
** '''2026''': Tier 1 EUR 0.1bn <sup>p. 32</sup>
*** '''o/w Grandfathered debt''': Tier 1: EUR 0.1bn <sup>p. 32</sup>
** '''2027''': Tier 2 EUR 2.4bn <sup>p. 32</sup>
** '''2027''': EUR 2.4bn (Tier 2) <sup>p. 32</sup>
** '''2028''': Tier 1 EUR 0.1bn, Senior debt EUR 0.5bn <sup>p. 32</sup>
** '''2028''': EUR 0.6bn total (Tier 1: EUR 0.1bn; Senior debt: EUR 0.5bn) <sup>p. 32</sup>
** '''2029''': Tier 2 EUR 2.0bn <sup>p. 32</sup>
*** '''o/w Grandfathered debt''': Tier 1: EUR 0.1bn <sup>p. 32</sup>
** '''2030''': Tier 2 EUR 0.7bn, Senior debt EUR 0.9bn <sup>p. 32</sup>
** '''2029''': EUR 2.0bn (Tier 2) <sup>p. 32</sup>
** '''2031-2039''': Tier 1 EUR 0.4bn, Tier 2 EUR 6.4bn, Senior debt EUR 1.5bn <sup>p. 32</sup>
** '''2030''': EUR 0.9bn total (Tier 2: EUR 0.7bn; Senior debt: EUR 0.2bn) <sup>p. 32</sup>
** '''>=2040''': Senior debt EUR 0.5bn <sup>p. 32</sup>
*** '''o/w Grandfathered debt''': Tier 2: EUR 0.7bn <sup>p. 32</sup>
** '''Undated''': Tier 1 EUR 4.0bn, Tier 2 EUR 0.7bn <sup>p. 32</sup>
** '''Of which grandfathered debt''':
** '''2031-2039''': EUR 8.3bn total (Tier 1: EUR 0.4bn; Tier 2: EUR 6.4bn; Senior debt: EUR 1.5bn) <sup>p. 32</sup>
*** '''o/w Grandfathered debt''': Tier 1: EUR 0.4bn <sup>p. 32</sup>
*** '''Tier 1''': 2026 EUR 0.1bn, 2028 EUR 0.1bn, 2031-2039 EUR 0.4bn, Undated EUR 0.8bn <sup>p. 32</sup>
** '''≥2040''': EUR 0.5bn (Senior debt) <sup>p. 32</sup>
*** '''Tier 2''': 2030 EUR 0.7bn, 2031-2039 EUR 0.2bn <sup>p. 32</sup>
* '''Debt calls''' in January 2026: AXA called the remaining Tier 2 grandfathered GBP 139m due 2054 callable 2034 5.625% issued January 2014, and the Tier 1 grandfathered EUR 250m perpetual callable 2010 floating issued January 2005 <sup>p. 32</sup>.
*** '''o/w Grandfathered debt''': Tier 2: EUR 0.2bn <sup>p. 32</sup>
* '''Economic maturity definition''': Economic maturity takes into account the first date of step-up calls on institutionally placed subordinated debt <sup>p. 32</sup>. For Solvency II RT1 debt with no step-up, the undated nature of the instrument is retained <sup>p. 32</sup>.
** '''Undated''': EUR 4.7bn total (Tier 1: EUR 4.0bn; Tier 2: EUR 0.7bn) <sup>p. 32</sup>
*** '''o/w Grandfathered debt''': Tier 1: EUR 0.8bn <sup>p. 32</sup>
* '''Subsequent events''': In January 2026, AXA called the remaining Tier 2 grandfathered GBP 139m due 2054 callable 2034 (5.625% issued January 2014) and the Tier 1 grandfathered EUR 250m perpetual callable 2010 floating issued January 2005 <sup>p. 32</sup>.
* '''Economic maturity methodology''': Economic maturity takes into account the first date of step-up calls on institutionally placed subordinated debt; for Solvency II RT1 debt with no step-up, the undated nature of the instrument is retained <sup>p. 32</sup>.


=== General Account Invested Assets ===
=== General Account invested assets ===

* '''Total General Account''' invested assets at EUR 450bn for FY25 <sup>p. 33</sup>
* '''Duration gap''' at -0.4 year <sup>p. 33</sup>
* (donut) '''FY25 Total General Account invested assets''': EUR 450bn total; segments include Fixed income, Real estate, Infrastructure equity, Listed equities, Private equity and hedge funds, Cash, and Policy loans <sup>p. 33</sup>


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| class="wikitable fintable"
{| class="wikitable fintable"
|+ FY25 Total General Account invested assets breakdown <sup>p. 33</sup>
|+ Invested assets (100%) in Euro billion <sup>p. 33</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! style="text-align:left" | Invested assets (100%) In EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | Value
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | % of total
! class="col-s" style="text-align:right" | %
|-
|-
| style="text-align:left" | Fixed income
| style="text-align:left" | '''Fixed income'''
| style="text-align:right" | 345
| style="text-align:right" | 345
| style="text-align:right" | 77%
| style="text-align:right" | 77%
|-
|-
| style="text-align:left" | Government bonds
| style="text-align:left" | ''o/w Government bonds''
| style="text-align:right" | 167
| style="text-align:right" | 167
| style="text-align:right" | 37%
| style="text-align:right" | 37%
|-
|-
| style="text-align:left" | Corporate bonds and loans
| style="text-align:left" | ''o/w Corporate bonds and loans''
| style="text-align:right" | 121
| style="text-align:right" | 121
| style="text-align:right" | 27%
| style="text-align:right" | 27%
|-
|-
| style="text-align:left" | Other fixed income
| style="text-align:left" | ''o/w Other fixed income¹''
| style="text-align:right" | 56
| style="text-align:right" | 56
| style="text-align:right" | 13%
| style="text-align:right" | 13%
|-
|-
| style="text-align:left" | Real estate
| style="text-align:left" | '''Real estate'''
| style="text-align:right" | 41
| style="text-align:right" | 41
| style="text-align:right" | 9%
| style="text-align:right" | 9%
|-
|-
| style="text-align:left" | Infrastructure equity
| style="text-align:left" | '''Infrastructure equity'''
| style="text-align:right" | 10
| style="text-align:right" | 10
| style="text-align:right" | 2%
| style="text-align:right" | 2%
|-
|-
| style="text-align:left" | Listed equities
| style="text-align:left" | '''Listed equities²'''
| style="text-align:right" | 10
| style="text-align:right" | 10
| style="text-align:right" | 2%
| style="text-align:right" | 2%
|-
|-
| style="text-align:left" | Private equity and hedge funds
| style="text-align:left" | '''Private equity and hedge funds³'''
| style="text-align:right" | 23
| style="text-align:right" | 23
| style="text-align:right" | 5%
| style="text-align:right" | 5%
|-
|-
| style="text-align:left" | Cash
| style="text-align:left" | '''Cash'''
| style="text-align:right" | 19
| style="text-align:right" | 19
| style="text-align:right" | 4%
| style="text-align:right" | 4%
|-
|-
| style="text-align:left" | Policy loans
| style="text-align:left" | '''Policy loans'''
| style="text-align:right" | 2
| style="text-align:right" | 2
| style="text-align:right" | 0%
| style="text-align:right" | 0%
|-
|-
| style="text-align:left" | '''Total Insurance Invested Assets'''
| style="text-align:left" | '''Total Insurance Invested Assets⁴'''
| style="text-align:right" | '''450'''
| style="text-align:right" | '''450'''
| style="text-align:right" | '''100%'''
| style="text-align:right" | '''100%'''
Line 1,094: Line 1,029:
</div>
</div>


* '''Other fixed income''' includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn) <sup>p. 33</sup>
* Total General Account invested assets EUR 450bn for FY25
* '''Listed equities''' includes hedges; listed equities excluding hedges at EUR 14bn <sup>p. 33</sup>
* Duration gap at -0.4 year
* '''Private equity and hedge funds''' includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn) <sup>p. 33</sup>
* Invested assets portfolio breakdown (reported in EUR billion):
* Other fixed income includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn)
* Listed equities includes hedges, with listed equities excluding hedges at EUR 14bn
* Private equity and hedge funds includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn)


=== Structured and Private Credit assets ===
=== Structured and Private Credit assets ===
Line 1,105: Line 1,037:
<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| class="wikitable fintable"
{| class="wikitable fintable"
|+ Structured and private credit assets <sup>p. 34</sup>
|+ Structured and Private Credit assets FY25 <sup>p. 34</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! style="text-align:left" | Invested assets (100%) In EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | Value
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | % of total G/A portfolio
! class="col-s" style="text-align:right" | % of total G/A¹ portfolio
! class="col-m" style="text-align:right" | Comments
|-
| style="text-align:left; font-weight:bold" | Total structured and private credit assets
| style="text-align:right; font-weight:bold" | 69
| style="text-align:right; font-weight:bold" | 15%
|-
|-
| style="text-align:left" | Residential mortgages
| style="text-align:left" | Residential Mortgages
| style="text-align:right" | 16
| style="text-align:right" | 16
| style="text-align:right" | 4%
| style="text-align:right" | 4%
| style="text-align:right" | - EUR 6bn Dutch mortgages, NHG guaranteed - EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)
|-
|-
| style="text-align:left" | CLO & ABS
| style="text-align:left" | CLO & ABS
| style="text-align:right" | 25
| style="text-align:right" | 25
| style="text-align:right" | 6%
| style="text-align:right" | 6%
| style="text-align:right" | - 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)
|-
|-
| style="text-align:left" | Infrastructure debt
| style="text-align:left" | Infrastructure debt
| style="text-align:right" | 8
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | 2%
| style="text-align:right" | - Skewed towards resilient industries (Telecom, Utilities, Transport)
|-
|-
| style="text-align:left" | CRE debt
| style="text-align:left" | CRE debt
| style="text-align:right" | 8
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | 2%
| style="text-align:right" | - Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV
|-
|-
| style="text-align:left" | Mid-market lending
| style="text-align:left" | Mid-Market lending
| style="text-align:right" | 10
| style="text-align:right" | 10
| style="text-align:right" | 2%
| style="text-align:right" | 2%
| style="text-align:right" | - Strong diversification with EUR 8m average ticket - Investments through SMAs with strict underwriting guidelines : senior secured, covenants, restrictions on asset sales and sector allocation
|-
|-
| style="text-align:left" | Other structured assets
| style="text-align:left" | Other
| style="text-align:right" | 2
| style="text-align:right" | 2
| style="text-align:right" | 0%
| style="text-align:right" | 0%
| style="text-align:right" | —
|-
| style="text-align:left" | '''Total Structured and Private Credit Assets'''
| style="text-align:right" | '''69'''
| style="text-align:right" | '''15%'''
| style="text-align:right" | o/w 54% participating
|}
|}
</div>
</div>


* '''General Account''' (G/A) refers to General Account <sup>p. 34</sup>.
* Total structured and private credit assets with 54% participating
* Residential mortgages:
* Includes EUR 6bn Dutch mortgages, NHG guaranteed.
* Includes EUR 10bn self-originated mortgages in Switzerland (56% LTV) and Germany (45% LTV).
* CLO & ABS: 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA).
* Infrastructure debt: skewed towards resilient industries including telecom, utilities, and transport.
* CRE debt: showing strong sector diversification (mainly logistics, residential, and retail), mostly in Europe, and circa 60% LTV.
* Mid-market lending: featuring strong diversification with EUR 8m average ticket size; investments made through SMAs with strict underwriting guidelines (senior secured, covenants, restrictions on asset sales and sector allocation).


=== Investment portfolio | Fixed Income reinvestment ===
=== Investment portfolio | Fixed Income reinvestment ===


* '''Fixed income reinvestment''' totaled EUR 57bn in FY25 <sup>p. 35</sup>.
* '''Fixed income reinvestment''' totaled EUR 57bn in FY25 <sup>p. 35</sup>
* (donut) '''FY25 Fixed Income Reinvestment''' asset allocation:
* (donut) '''FY25 Fixed income reinvestment''' asset mix:
** Government bonds & related: 32% (average rating: AA) <sup>p. 35</sup>
** Government bonds & related: 32% (average rating: AA) <sup>p. 35</sup>
** Investment grade credit: 40% (average rating: A) <sup>p. 35</sup>
** Investment grade credit: 40% (average rating: A) <sup>p. 35</sup>
** ABS/CLO/IG fund financing: 21% <sup>p. 35</sup>
** ABS/CLO/IG fund financing: 21% <sup>p. 35</sup>
** Below investment grade credit: 7% <sup>p. 35</sup>
** Below investment grade credit: 7% <sup>p. 35</sup>
* (bar) '''FY25 Fixed Income Reinvestment Yield''':
* (bar) '''FY25 Fixed income reinvestment yield''':
** Public fixed income (government and corporate bonds and related): 3.5% <sup>p. 35</sup>
** Public fixed income: 3.5% <sup>p. 35</sup>
** Private & Structured fixed income (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid): 4.7% <sup>p. 35</sup>
** Private & Structured fixed income: 4.7% <sup>p. 35</sup>
** Total fixed income: 3.9% <sup>p. 35</sup>
** Total fixed income: 3.9% <sup>p. 35</sup>
* '''Reinvestment yield''' achieved at 3.9% on EUR 57bn invested <sup>p. 35</sup>:
* '''Reinvestment yield''' achieved at 3.9% on EUR 57bn invested <sup>p. 35</sup>:
Line 1,167: Line 1,100:


=== Table of contents ===
=== Table of contents ===

* '''Table of contents''' agenda overview:
** 1. Debt and Invested Assets <sup>p. 31</sup>
** '''2. Additional P&C disclosures''' (active section) <sup>p. 36</sup>
** 3. Additional IFRS17 disclosures <sup>p. 41</sup>
** 4. Sustainability <sup>p. 44</sup>


=== AXA XL Insurance | Large Commercial & Specialty business ===
=== AXA XL Insurance | Large Commercial & Specialty business ===
Line 1,178: Line 1,105:
<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| class="wikitable fintable"
{| class="wikitable fintable"
|+ AXA XL Insurance FY25 GWP <sup>p. 37</sup>
|+ FY25 GWP by line of business and geography <sup>p. 37</sup>
! style="text-align:left" | USD billion unless otherwise mentioned
! style="text-align:left" | USD billion unless otherwise mentioned
! class="col-s" style="text-align:right" | GWP by line of business
! class="col-s" style="text-align:right" | Casualty
! class="col-s" style="text-align:right" | GWP by geography
! class="col-s" style="text-align:right" | Property
! class="col-s" style="text-align:right" | Specialty
! class="col-s" style="text-align:right" | Professional lines (including Cyber)
! class="col-s" style="text-align:right" | Americas
! class="col-s" style="text-align:right" | Europe & APAC
! class="col-s" style="text-align:right" | UK & Lloyds
|-
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:left" | FY25 GWP
| style="text-align:right; font-weight:bold" | 19
| style="text-align:right" | 19
| style="text-align:right; font-weight:bold" | 19
| style="text-align:right" |
|-
| style="text-align:left" | '''Line of business'''
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Casualty
| style="text-align:right" | 35%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Property
| style="text-align:right" | 29%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Specialty
| style="text-align:right" | 19%
| style="text-align:right" | —
| style="text-align:right" | —
|-
|-
| style="text-align:left" | Professional lines (including Cyber)
| style="text-align:left" | Share
| style="text-align:right" | 35%
| style="text-align:right" | 29%
| style="text-align:right" | 19%
| style="text-align:right" | 17%
| style="text-align:right" | 17%
| style="text-align:right" |
| style="text-align:right" | 46%
| style="text-align:right" | 35%
| style="text-align:right" | 19%
|}
</div>

* '''Market leadership''' positions AXA XL in the top 3 globally for <sup>p. 37</sup>:
** Multinational Programs <sup>p. 37</sup>
** Marine <sup>p. 37</sup>
** Fine Art & Specie <sup>p. 37</sup>
* '''Cycle management''' is utilized to deliver consistent profitability <sup>p. 37</sup>:
** (bubble chart) '''Profitability vs Ex-price growth (%)''': shows relative positioning of key lines <sup>p. 37</sup>:
*** '''Property''': high profitability, high ex-price growth <sup>p. 37</sup>
*** '''Specialty''': moderate-high profitability, moderate ex-price growth <sup>p. 37</sup>
*** '''Casualty''': moderate profitability, moderate ex-price growth <sup>p. 37</sup>
*** '''Professional lines''': lower profitability, lower ex-price growth <sup>p. 37</sup>

=== P&C | Focus on Reserves ===

<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Claims and Technical reserves ratio <sup>p. 38</sup>
! style="text-align:left" | %
! class="col-s" style="text-align:right" | FY18
! class="col-s" style="text-align:right" | FY19
! class="col-s" style="text-align:right" | FY20
! class="col-s" style="text-align:right" | FY21
! class="col-s" style="text-align:right" | FY22
! class="col-s" style="text-align:right" | FY23
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
|-
| style="text-align:left" | '''Geography'''
| style="text-align:left" | Claims reserves ratio (IFRS4 basis)
| style="text-align:right" | 179%
| style="text-align:right" | 185%
| style="text-align:right" | 193%
| style="text-align:right" | 188%
| style="text-align:right" | 189%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
|-
| style="text-align:left" | Americas
| style="text-align:left" | Claims reserves ratio (IFRS17 basis)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 46%
| style="text-align:right" |
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 198%
| style="text-align:right" | 195%
| style="text-align:right" | 180%
| style="text-align:right" | 175%
|-
|-
| style="text-align:left" | Europe & APAC
| style="text-align:left" | Technical reserves ratio (IFRS4 basis)
| style="text-align:right" | 213%
| style="text-align:right" | 227%
| style="text-align:right" | 233%
| style="text-align:right" | 226%
| style="text-align:right" | 227%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 35%
|-
|-
| style="text-align:left" | UK & Lloyds
| style="text-align:left" | Technical reserves ratio (IFRS17 basis)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 19%
| style="text-align:right" |
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 234%
| style="text-align:right" | 232%
| style="text-align:right" | 216%
| style="text-align:right" | 210%
|}
|}
</div>
</div>


* ¹ Includes net undiscounted claims reserves and unearned premium reserves <sup>p. 38</sup>.
* '''AXA XL Insurance''' is well diversified across lines of business and geographies, holding leading market positions across lines.
* '''Leading market positions''' globally, ranking Top 3 in:
** Multinational Programs
** Marine
** Fine Art & Specie
* (bubble chart) '''Managing the cycle''' to deliver consistent profitability (Profitability vs Ex-price growth):
** '''Property''': High profitability, high ex-price growth
** '''Specialty''': Medium profitability, medium-high ex-price growth
** '''Casualty''': Medium-low profitability, medium ex-price growth
** '''Professional lines''': Low profitability, low ex-price growth

=== P&C | Focus on Reserves ===

* (bar chart) '''Claims reserves ratio''' (Net undiscounted claims reserves / Net earned premiums) <sup>p. 38</sup>:
** '''IFRS4''': FY18 179%, FY19 185%, FY20 193%, FY21 188%, FY22 189% <sup>p. 38</sup>
** '''IFRS17''': FY22 198%, FY23 195%, FY24 180%, FY25 175% <sup>p. 38</sup>
* (bar chart) '''Technical reserves ratio''' (Net undiscounted technical reserves / Net earned premiums) <sup>p. 38</sup>:
** '''IFRS4''': FY18 213%, FY19 227%, FY20 233%, FY21 226%, FY22 227% <sup>p. 38</sup>
** '''IFRS17''': FY22 234%, FY23 232%, FY24 216%, FY25 210% <sup>p. 38</sup>
* '''Technical reserves''' include net undiscounted claims reserves and unearned premium reserves <sup>p. 38</sup>.


=== P&C | 2026 Simplified Group Nat Cat Reinsurance Program 1 ===
=== P&C | 2026 Simplified Group Nat Cat Reinsurance Program 1 ===


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| class="wikitable fintable"
{| class="wikitable"
|+ Insurance segment (occurrence protection) capacity and retention by peril <sup>p. 39</sup>
|+ Insurance segment occurrence protection capacity and retention by peril <sup>p. 39</sup>
! style="text-align:left" | EUR billion
! style="text-align:left" | Peril
! class="col-s" style="text-align:right" | Capacity
! class="col-s" style="text-align:right" | Capacity
! class="col-s" style="text-align:right" | Retention
! class="col-s" style="text-align:right" | Retention
|-
|-
| style="text-align:left" | EU Windstorm
| style="text-align:left" | EU Windstorm
| style="text-align:right" | 4.0
| class="col-s" style="text-align:right" | EUR 4.0bn
| style="text-align:right" | 600m
| class="col-s" style="text-align:right" | EUR 600m
|-
|-
| style="text-align:left" | Europe Flood
| style="text-align:left" | Europe Flood
| style="text-align:right" | 2.1
| class="col-s" style="text-align:right" | EUR 2.1bn
| style="text-align:right" | 450m
| class="col-s" style="text-align:right" | EUR 450m
|-
|-
| style="text-align:left" | Europe Earthquake
| style="text-align:left" | Europe Earthquake
| style="text-align:right" | 2.1
| class="col-s" style="text-align:right" | EUR 2.1bn
| style="text-align:right" | 400m
| class="col-s" style="text-align:right" | EUR 400m
|-
|-
| style="text-align:left" | NA Hurricane
| style="text-align:left" | NA Hurricane
| style="text-align:right" | 1.2
| class="col-s" style="text-align:right" | EUR 1.2bn
| style="text-align:right" | 600m
| class="col-s" style="text-align:right" | EUR 600m
|-
|-
| style="text-align:left" | NA Earthquake
| style="text-align:left" | NA Earthquake
| style="text-align:right" | 1.2
| class="col-s" style="text-align:right" | EUR 1.2bn
| style="text-align:right" | 600m
| class="col-s" style="text-align:right" | EUR 600m
|-
|-
| style="text-align:left" | Per other perils
| style="text-align:left" | Per other perils
| style="text-align:right" | —
| class="col-s" style="text-align:right" | —
| style="text-align:right" | 400m
| class="col-s" style="text-align:right" | EUR 400m
|}
|}
</div>
</div>
* Retention levels remained stable in 2026 compared to 2025 <sup>p. 39</sup>.
* NA Hurricane: varying retention between EUR 400m MX and EUR 600m NA <sup>p. 39</sup>
* NA Earthquake: varying retention between EUR 400m MX and EUR 600m NA <sup>p. 39</sup>
* Per other perils: capacity varies by peril type; other perils include Turkey earthquake, Other Europe and NA perils, South America Earthquake, and other secondary perils <sup>p. 39</sup>
* (diagram) Reinsurance segment (illustrative) utilizes Alternative Capital & Cat Bonds <sup>p. 39</sup>.


* '''Retention levels''' remained stable in 2026 compared to 2025 <sup>p. 39</sup>.
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 ===
* (diagram) '''Reinsurance segment''' (illustrative) utilizes Alternative Capital & Cat Bonds <sup>p. 39</sup>.

=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 ===


<div style="overflow-x:auto">
<div style="overflow-x:auto">
Line 1,294: Line 1,251:
! class="col-s" style="text-align:right" | EUR billion
! class="col-s" style="text-align:right" | EUR billion
|-
|-
| style="text-align:left" | 95th percentile (1/20y)
| style="text-align:left" | 1/20y (95th percentile)
| style="text-align:right" | -1.2
| style="text-align:right" | -1.2
|-
|-
| style="text-align:left" | 90th percentile (1/10y)
| style="text-align:left" | 1/10y (90th percentile)
| style="text-align:right" | -0.8
| style="text-align:right" | -0.8
|-
|-
| style="text-align:left" | 80th percentile (1/5y)
| style="text-align:left" | 1/5y (80th percentile)
| style="text-align:right" | -0.4
| style="text-align:right" | -0.4
|-
|-
| style="text-align:left" | 50th percentile (Median)
| style="text-align:left" | Median (50th percentile)
| style="text-align:right" | +0.1
| style="text-align:right" | +0.1
|-
|-
| style="text-align:left" | 20th percentile (1/5y)
| style="text-align:left" | 1/5y (20th percentile)
| style="text-align:right" | +0.5
| style="text-align:right" | +0.5
|-
|-
| style="text-align:left" | 10th percentile (1/10y)
| style="text-align:left" | 1/10y (10th percentile)
| style="text-align:right" | +0.7
| style="text-align:right" | +0.7
|-
|-
| style="text-align:left" | 5th percentile (1/20y)
| style="text-align:left" | 1/20y (5th percentile)
| style="text-align:right" | +0.8
| style="text-align:right" | +0.8
|}
|}
Line 1,320: Line 1,277:
{| class="wikitable"
{| class="wikitable"
|+ Average expected Nat Cat charges net of reinsurance, pre-tax <sup>p. 40</sup>
|+ Average expected Nat Cat charges net of reinsurance, pre-tax <sup>p. 40</sup>
! style="text-align:left" | EUR billion
! style="text-align:left" | Year
! class="col-xs" style="text-align:right" | 2025
! class="col-s" style="text-align:right" | EUR billion
! class="col-xs" style="text-align:right" | 2026
! class="col-s" style="text-align:right" | Estimated impact on GEP
|-
|-
| style="text-align:left" | Average expected Nat Cat charges
| style="text-align:left" | 2025
| class="col-xs" style="text-align:right" | 2.6
| class="col-s" style="text-align:right" | 2.6
| class="col-xs" style="text-align:right" | 2.7
| class="col-s" style="text-align:right" | ca. 4.5%
|-
|-
| style="text-align:left" | Estimated impact on GEP
| style="text-align:left" | 2026
| class="col-xs" style="text-align:right" | ca. 4.5%
| class="col-s" style="text-align:right" | 2.7
| class="col-xs" style="text-align:right" | ca. 4.5%
| class="col-s" style="text-align:right" | ca. 4.5%
|}
|}
</div>
</div>

* Earnings deviation basis: Group underlying earnings deviation to average Nat Cat charges in 2026 net of reinsurance, post-tax, in EUR billion <sup>p. 40</sup>.
* More severe years (negative deviation in ca. 40% of cases) <sup>p. 40</sup>:
* '''Earnings deviation''' from average Nat Cat charges in 2026 (net of reinsurance, post-tax) shows asymmetric distribution <sup>p. 40</sup>:
* Less severe years (positive deviation in ca. 60% of cases) <sup>p. 40</sup>:
** '''More severe years''' result in negative deviation in ca. 40% of cases <sup>p. 40</sup>.
** '''Less severe years''' result in positive deviation in ca. 60% of cases <sup>p. 40</sup>.
* Nat Cat definition: Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance <sup>p. 40</sup>.
* Deviation baseline: Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year, representing ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance <sup>p. 40</sup>.


=== Table of contents ===
=== Table of contents ===


=== P&C | Margin analysis ===
* '''Table of contents''' section divider <sup>p. 41</sup>:
** 1. Debt and Invested Assets <sup>p. 31</sup>
** 2. Additional P&C disclosures <sup>p. 36</sup>
** '''3. Additional IFRS17 disclosures''' <sup>p. 41</sup>
** 4. Sustainability <sup>p. 44</sup>

=== P&C | Margin Analysis ===

* (flow) '''P&C Margin Analysis''' (in EUR million pre-tax, changes versus FY24 at constant FX) <sup>p. 42</sup>:
** '''Technical Result''' components:
*** '''Current Accident Year Undiscounted Technical Margin''': EUR 2,778m (change: +EUR 707m) <sup>p. 42</sup>
**** Gross Earned Premiums: EUR 57,656m (+6%) <sup>p. 42</sup>
**** Current Accident Year Undiscounted Combined Ratio: 95.2% (-1.0pt) <sup>p. 42</sup>
**** ''o/w Nat Cats'': 3.4% (-0.4pt) <sup>p. 42</sup>
*** '''Current Accident Year Discounting''': EUR 2,009m (change: +EUR 115m) <sup>p. 42</sup>
**** Discounting Ratio (in Combined Ratio points): -3.5% (+0.0pt) <sup>p. 42</sup>
**** Current Accident Year Net Claims reserves: EUR 19.0bn <sup>p. 42</sup>
**** Duration: 4.0 years <sup>p. 42</sup>
**** Current Accident Year Discount rate: 2.8% <sup>p. 42</sup>
*** '''Prior Years' Reserve Development (PYD)''': EUR 622m (change: -EUR 341m) <sup>p. 42</sup>
**** PYD ratio: -1.1% (+0.7pt) <sup>p. 42</sup>
** '''Financial Result''' components:
*** '''Investment Income''': EUR 3,988m (change: +EUR 435m) <sup>p. 42</sup>
**** FY25 Average Assets: EUR 115bn <sup>p. 42</sup>
**** Asset book yield: 3.5% <sup>p. 42</sup>
**** FY25 Reinvestment yield (on fixed income assets): 4.3% <sup>p. 42</sup>
*** '''Insurance Finance Expenses''': -EUR 1,358m (change: -EUR 235m) <sup>p. 42</sup>
**** FY24 Reserves at locked-in rate: EUR 71bn <sup>p. 42</sup>
**** Liability book yield: 1.9% <sup>p. 42</sup>
** '''Underlying Earnings before tax''': EUR 8,040m (change: +EUR 681m) <sup>p. 42</sup>
*** Tax: -EUR 2,060m (change: -EUR 169m) <sup>p. 42</sup>
*** Affiliates, Minority interests & Other: -EUR 108m (change: -EUR 10m) <sup>p. 42</sup>
*** '''Underlying Earnings''': EUR 5,872m (change: +EUR 501m, +9% growth vs. FY24 at constant FX) <sup>p. 42</sup>
* '''FY25 sensitivity''' to Current Accident Year discount rate changes (parallel shift of the full-year average yield curve used for discounting FY25 current accident year net reserve) <sup>p. 42</sup>:
** +25bps: +EUR 0.2bn <sup>p. 42</sup>
** -25bps: -EUR 0.2bn <sup>p. 42</sup>
* '''2026e Insurance Finance Expenses''' (pre-tax): ~ -EUR 1.4bn <sup>p. 42</sup>
** Sensitivity of 2026e Insurance Finance Expenses to changes in 2025 current AY Discount <sup>p. 42</sup>:
*** +25bps: ~ -EUR 50m <sup>p. 42</sup>
*** -25bps: ~ +EUR 50m <sup>p. 42</sup>

=== L&H | Margin Analysis ===

* '''L&H Margin Analysis''' includes scope impact; changes are versus FY24 at constant FX <sup>p. 43</sup>.

=== Technical Result (in EUR million, pre-tax) ===


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| class="wikitable fintable"
{| class="wikitable"
|+ Technical Margin, FY25 vs FY24 <sup>p. 43</sup>
|+ P&C Underlying Earnings Bridge FY25 <sup>p. 42</sup>
! style="text-align:left" | EUR million unless otherwise mentioned
! style="text-align:left" | Metric
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
! class="col-s" style="text-align:right" | Change
|-
|-
| style="text-align:left" | Short-term Technical Margin
| style="text-align:left" | '''Underlying earnings before tax'''
| style="text-align:right" | 479
| class="col-s" style="text-align:right" | EUR 8,040m
| style="text-align:right" | +60
| class="col-s" style="text-align:right" | +EUR 681m
|-
|-
| style="text-align:left" | Gross Earned Premiums
| style="text-align:left" | '''Tax'''
| style="text-align:right" | 17,416
| class="col-s" style="text-align:right" | -EUR 2,060m
| style="text-align:right" | +10%
| class="col-s" style="text-align:right" | -EUR 169m
|-
|-
| style="text-align:left" | Combined Ratio (all year)
| style="text-align:left" | '''Affiliates, minority interests & other'''
| style="text-align:right" | 97.2%
| class="col-s" style="text-align:right" | -EUR 108m
| style="text-align:right" | -0.1pts
| class="col-s" style="text-align:right" | -EUR 10m
|-
|-
| style="text-align:left" | Long-term Technical Margin
| style="text-align:left" | '''Underlying earnings'''
| style="text-align:right" | 2,804
| class="col-s" style="text-align:right" | EUR 5,872m
| style="text-align:right" | +156
| class="col-s" style="text-align:right" | +EUR 501m
|-
| style="text-align:left" | CSM release
| style="text-align:right" | 2,954
| style="text-align:right" | +215
|-
|-
| style="text-align:left" | Technical experience
| style="text-align:left" | '''Growth vs. FY24 (at constant FX)'''
| style="text-align:right" | -150
| class="col-s" style="text-align:right" |
| style="text-align:right" | -58
| class="col-s" style="text-align:right" | +9%
|}
|}
</div>
</div>
* Short-term Technical Margin includes the recapture of Laya.

=== Financial Result (in EUR million, pre-tax) ===


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| class="wikitable fintable"
{| class="wikitable fintable"
|+ Investment Income and Insurance Finance Expenses, non-VFA <sup>p. 43</sup>
|+ P&C margin bridge components (in EUR million, pre-tax, changes versus FY24 at constant FX) <sup>p. 42</sup>
! style="text-align:left" | EUR million
! style="text-align:left" | Component
! class="col-s" style="text-align:right" | Value
! class="col-s" style="text-align:right" | Value
! class="col-s" style="text-align:right" | Change
! class="col-s" style="text-align:right" | Change
! class="col-m" style="text-align:right" | Other metrics
|-
|-
| style="text-align:left" | Investment Income
| style="text-align:left" | '''Current accident year undiscounted technical margin'''
| style="text-align:right" | 2,484
| style="text-align:right" | 2,778
| style="text-align:right" | -1
| style="text-align:right" | +707
| style="text-align:right" | Gross earned premiums: EUR 57,656m (+6%); Current accident year undiscounted combined ratio: 95.2% (-1.0pt); o/w Nat Cats: 3.4% (-0.4pt)
|-
|-
| style="text-align:left" | Insurance Finance Expenses
| style="text-align:left" | '''Current accident year discounting'''
| style="text-align:right" | -1,538
| style="text-align:right" | 2,009
| style="text-align:right" | -9
| style="text-align:right" | +115
| style="text-align:right" | Discounting ratio (in combined ratio points): -3.5% (+0.0pt); Current accident year net claims reserves: EUR 19.0bn; Duration: 4.0 years; Current accident year discount rate: 2.8%
|-
| style="text-align:left" | '''Prior years' reserve development (PYD)'''
| style="text-align:right" | 622
| style="text-align:right" | -341
| style="text-align:right" | PYD ratio: -1.1% (+0.7pt)
|-
| style="text-align:left" | '''Investment income'''
| style="text-align:right" | 3,988
| style="text-align:right" | +435
| style="text-align:right" | FY25 average assets: EUR 115bn; Asset book yield: 3.5%; FY25 reinvestment yield (on fixed income assets): 4.3%
|-
| style="text-align:left" | '''Insurance finance expenses'''
| style="text-align:right" | -1,358
| style="text-align:right" | -235
| style="text-align:right" | FY24 reserves at locked-in rate: EUR 71bn; Liability book yield: 1.9%
|}
|}
</div>
</div>
* Average Assets (FY25) were EUR 98bn.
* Asset book yield was 2.5%.
* Reinvestment yield (FY25 on fixed income assets) was 3.8%.
* Reserves at locked-in rate (FY24) were EUR 62bn.
* Liability book yield was 2.5%.

=== Earnings Bridge ===


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| class="wikitable fintable"
{| class="wikitable fintable"
|+ Underlying Earnings walk <sup>p. 43</sup>
|+ FY25 sensitivity to current accident year discount rate changes <sup>p. 42</sup>
! style="text-align:left" | EUR million
! style="text-align:left" | Change in discount rate
! class="col-s" style="text-align:right" | Value
! class="col-s" style="text-align:right" | Impact (EUR billion)
! class="col-s" style="text-align:right" | Change
|-
|-
| style="text-align:left" | Underlying Earnings before tax
| style="text-align:left" | +25bps
| style="text-align:right" | 4,229
| style="text-align:right" | +0.2
| style="text-align:right" | +205
|-
|-
| style="text-align:left" | Tax
| style="text-align:left" | -25bps
| style="text-align:right" | -800
| style="text-align:right" | -0.2
|}
| style="text-align:right" | +65
</div>

<div style="overflow-x:auto">
{| class="wikitable"
|+ Sensitivity of 2026e insurance finance expenses to changes in 2025 current AY discount <sup>p. 42</sup>
! style="text-align:left" | Change in 2025 current AY discount
! class="col-s" style="text-align:right" | Impact (EUR million)
|-
|-
| style="text-align:left" | Affiliates and minorities (including other)
| style="text-align:left" | +25bps
| style="text-align:right" | 72
| class="col-s" style="text-align:right" | ~-50
| style="text-align:right" | -51
|-
|-
| style="text-align:left" | Underlying Earnings
| style="text-align:left" | -25bps
| style="text-align:right" | 3,501
| class="col-s" style="text-align:right" | ~+50
| style="text-align:right" | +219
|}
|}
</div>
</div>
* Underlying Earnings represents +7% growth versus FY24 at constant FX.


* '''Technical result''' and '''Financial result''' components sum to underlying earnings before tax <sup>p. 42</sup>.
=== Life & Health FY25 CSM Key Sensitivities (in EUR billion) ===
* '''2026e insurance finance expenses''' (pre-tax): ~-EUR 1.4bn <sup>p. 42</sup>

=== L&H | Margin analysis ===


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| class="wikitable fintable"
{| class="wikitable fintable"
|+ CSM Sensitivity <sup>p. 43</sup>
|+ Life & Health FY25 CSM Key Sensitivities (in Euro billion) <sup>p. 43</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | +50bps / +25%
! class="col-s" style="text-align:right" | Impact on CSM
! class="col-s" style="text-align:right" | -50bps / -25%
|-
|-
| style="text-align:left" | CSM Baseline
| style="text-align:left" | '''Baseline'''
| style="text-align:right" | 33.3
| style="text-align:right" | '''33.3'''
| style="text-align:right" | —
|-
|-
| style="text-align:left" | Interest rate sensitivity
| style="text-align:left" | Interest rates +50bps
| style="text-align:right" | -0.8
| style="text-align:right" | -0.8
| style="text-align:right" | +0.6
|-
|-
| style="text-align:left" | Sovereign spread sensitivity
| style="text-align:left" | Interest rates -50bps
| style="text-align:right" | 0.6
|-
| style="text-align:left" | Sovereign spreads +50bps
| style="text-align:right" | -1.9
| style="text-align:right" | -1.9
| style="text-align:right" | +1.9
|-
|-
| style="text-align:left" | Corporate spread sensitivity
| style="text-align:left" | Sovereign spreads -50bps
| style="text-align:right" | 1.9
|-
| style="text-align:left" | Corporate spread +50bps
| style="text-align:right" | -0.8
| style="text-align:right" | -0.8
| style="text-align:right" | +0.7
|-
|-
| style="text-align:left" | Equity sensitivity
| style="text-align:left" | Corporate spread -50bps
| style="text-align:right" | +1.8
| style="text-align:right" | 0.7
|-
| style="text-align:left" | Equities +25%
| style="text-align:right" | 1.8
|-
| style="text-align:left" | Equities -25%
| style="text-align:right" | -2.2
| style="text-align:right" | -2.2
|}
|}
</div>
</div>


<div style="overflow-x:auto">
=== Table of contents ===
{| class="wikitable"
|+ Life & Health Financials (pre-tax) <sup>p. 43</sup>
! style="text-align:left" | Metric
! class="col-m" style="text-align:right" | Value
! class="col-m" style="text-align:right" | LFL Change
! class="col-m" style="text-align:right" | Other metrics
|-
| style="text-align:left" | '''Short-term Technical Margin'''
| class="col-m" style="text-align:right" | EUR 479m
| class="col-m" style="text-align:right" | +EUR 60m
| class="col-m" style="text-align:right" | Gross earned premiums: EUR 17,416m (+10% LFL); All year combined ratio: 97.2% (-0.1pts)
|-
| style="text-align:left" | '''Long-term Technical Margin'''
| class="col-m" style="text-align:right" | EUR 2,804m
| class="col-m" style="text-align:right" | +EUR 156m
| class="col-m" style="text-align:right" | CSM release: EUR 2,954m (+EUR 215m LFL); Technical experience: EUR -150m (-EUR 58m LFL)
|-
| style="text-align:left" | '''Investment Income (non-VFA only)'''
| class="col-m" style="text-align:right" | EUR 2,484m
| class="col-m" style="text-align:right" | -EUR 1m
| class="col-m" style="text-align:right" | Average assets: EUR 98bn; Asset book yield: 2.5%; Reinvestment yield: 3.8% on fixed income assets
|-
| style="text-align:left" | '''Insurance Finance Expenses (non-VFA only)'''
| class="col-m" style="text-align:right" | EUR -1,538m
| class="col-m" style="text-align:right" | -EUR 9m
| class="col-m" style="text-align:right" | Reserves at locked-in rate: EUR 62bn (FY24); Liability book yield: 2.5%
|-
| style="text-align:left" | '''Underlying Earnings before tax'''
| class="col-m" style="text-align:right" | EUR 4,229m
| class="col-m" style="text-align:right" | +EUR 205m
| class="col-m" style="text-align:right" | Tax: EUR -800m (+EUR 65m LFL); Affiliates, minority interests & other: EUR 72m (-EUR 51m LFL)
|-
| style="text-align:left" | '''Underlying Earnings'''
| class="col-m" style="text-align:right" | EUR 3,501m
| class="col-m" style="text-align:right" | +EUR 219m
| class="col-m" style="text-align:right" | +7% at constant FX
|}
</div>


* '''Table of contents''' section navigation:
=== Table of contents ===
** 1. Debt and Invested Assets <sup>p. 31</sup>
** 2. Additional P&C disclosures <sup>p. 36</sup>
** 3. Additional IFRS17 disclosures <sup>p. 41</sup>
** 4. '''Sustainability''' <sup>p. 44</sup>


=== Expanding AXA's role in society: AXA for Progress Index 1 ===
=== Expanding AXA's role in society: AXA for Progress Index 1 ===
Line 1,517: Line 1,477:
<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| class="wikitable"
{| class="wikitable"
|+ AXA for Progress Index performance dashboard <sup>p. 45</sup>
|+ ESG Targets and 2025 Results <sup>p. 45</sup>
! style="text-align:left" | Pillar
! style="text-align:left" | Category
! class="col-m" style="text-align:right" | Metric
! class="col-m" style="text-align:right" | Target
! class="col-m" style="text-align:right" | Target
! class="col-m" style="text-align:right" | 2025 Result
! class="col-m" style="text-align:right" | 2025 Result
|-
|-
| style="text-align:left" | Global Investor
| style="text-align:left" | Climate transition financing
| class="col-m" style="text-align:right" | Climate transition financing
| class="col-m" style="text-align:right" | EUR 5bn per year
| class="col-m" style="text-align:right" | EUR 5.0bn per year
| class="col-m" style="text-align:right" | EUR 6.4bn
| class="col-m" style="text-align:right" | EUR 6.4bn
|-
|-
| style="text-align:left" | Global Investor
| style="text-align:left" | Community resilience financing
| class="col-m" style="text-align:right" | Community resilience financing
| class="col-m" style="text-align:right" | >EUR 500m per year
| class="col-m" style="text-align:right" | >EUR 500m per year
| class="col-m" style="text-align:right" | EUR 1.4bn
| class="col-m" style="text-align:right" | EUR 1.4bn
|-
|-
| style="text-align:left" | Global Insurer
| style="text-align:left" | Transition underwriting
| class="col-m" style="text-align:right" | Transition underwriting
| class="col-m" style="text-align:right" | EUR 6bn in P&C GWP (cumulative 2024-2026)
| class="col-m" style="text-align:right" | EUR 6.0bn in P&C GWP (cumulative 2024-2026)
| class="col-m" style="text-align:right" | EUR 4.6bn
| class="col-m" style="text-align:right" | EUR 4.6bn
|-
|-
| style="text-align:left" | Global Insurer
| style="text-align:left" | Climate adaptation solutions
| class="col-m" style="text-align:right" | Climate adaptation solutions
| class="col-m" style="text-align:right" | >20,000 (cumulative 2024-2026)
| class="col-m" style="text-align:right" | >20,000 (cumulative 2024-2026)
| class="col-m" style="text-align:right" | 19,698
| class="col-m" style="text-align:right" | 19,698 cumulative 2024-2025
|-
|-
| style="text-align:left" | Global Insurer
| style="text-align:left" | Inclusive insurance customers
| class="col-m" style="text-align:right" | Inclusive insurance customers
| class="col-m" style="text-align:right" | >20m by 2026
| class="col-m" style="text-align:right" | >20m by 2026
| class="col-m" style="text-align:right" | 20.6m
| class="col-m" style="text-align:right" | 20.6m
|-
|-
| style="text-align:left" | Company
| style="text-align:left" | Climate adaptation training
| class="col-m" style="text-align:right" | Employee climate training
| class="col-m" style="text-align:right" | >80,000 employees trained by 2026
| class="col-m" style="text-align:right" | >80,000 by 2026
| class="col-m" style="text-align:right" | 46,420
| class="col-m" style="text-align:right" | 46,420
|-
|-
| style="text-align:left" | Company
| style="text-align:left" | Carbon emissions reduction
| class="col-m" style="text-align:right" | Net-Zero contribution
| class="col-m" style="text-align:right" | -50% by 2030
| class="col-m" style="text-align:right" | -50% absolute carbon emissions by 2030
| class="col-m" style="text-align:right" | -64% reduction against 2019
| class="col-m" style="text-align:right" | -64% reduction against 2019
|-
|-
| style="text-align:left" | Company
| style="text-align:left" | Employee volunteering
| class="col-m" style="text-align:right" | Employee volunteering
| class="col-m" style="text-align:right" | 50% of employees engaged by 2026
| class="col-m" style="text-align:right" | 50% of employees by 2026
| class="col-m" style="text-align:right" | 56%
| class="col-m" style="text-align:right" | 56%
|}
|}
</div>
</div>
* '''AXA for Progress Index''' performance dashboard across three pillars: Global Investor, Global Insurer, and Company <sup>p. 45</sup>.
* '''Climate adaptation solutions''': Target of >20,000 climate adaptation solutions & services (cumulative 2024-2026; target revised in 2025 from >9,000) vs. 19,698 cumulative 2024-2025 result <sup>p. 45</sup>.
* '''Net-Zero contribution''': Target of -50% absolute carbon emissions by 2030 (scope: energy Scopes 1 and 2, car fleet, and business travel; baseline 2019) and offset of residual emissions via nature-based or technical carbon capture projects vs. -64% reduction against 2019 in 2025 <sup>p. 45</sup>.


=== Sustainability Performance & Ratings ===
=== Sustainability Performance & Ratings ===
Line 1,572: Line 1,520:
<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| class="wikitable"
{| class="wikitable"
|+ ESG ratings <sup>p. 46</sup>
|+ ESG Ratings and Scores <sup>p. 46</sup>
! style="text-align:left" | Rating Agency
! style="text-align:left" | Rating Agency
! class="col-m" style="text-align:right" | 2025 Score
! class="col-m" style="text-align:right" | 2025 Score
|-
|-
| style="text-align:left" | S&P Global
| style="text-align:left" | S&P Global
| class="col-m" style="text-align:right" | 97th percentile
| class="col-m" style="text-align:right" | 97th percentile in Dow Jones Best-in-Class Europe & World indices
|-
|-
| style="text-align:left" | MSCI
| style="text-align:left" | MSCI
Line 1,589: Line 1,537:
|-
|-
| style="text-align:left" | FTSE Russell
| style="text-align:left" | FTSE Russell
| class="col-m" style="text-align:right" | 4.3/5
| class="col-m" style="text-align:right" | 4.3/5 in FTSE4Good Index Series
|}
|}
</div>
</div>
* CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (specifically AXA Restricted Shares), with results as of February 6th, 2026
* The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (specifically AXA Restricted Shares), with results as of February 6th, 2026.
* '''FTSE Russell''' 2025 score: 4.3/5 in FTSE4Good Index Series <sup>p. 46</sup>


=== Scope ===
=== Scope ===


* '''France''' scope includes insurance activities, banking activities, and holding <sup>p. 47</sup>.
* '''France''' includes insurance activities, banking activities, and holding <sup>p. 47</sup>.
* '''Europe''' scope includes Switzerland (insurance), Germany (insurance and holding), Belgium and Luxembourg (insurance and holding), United Kingdom and Ireland (insurance and holding), Spain (insurance and holdings), Italy (insurance), Prima (insurance), and AXA Life Europe (insurance) <sup>p. 47</sup>.
* '''Europe''' includes Switzerland (insurance activities), Germany (insurance activities and holding), Belgium and Luxemburg (insurance activities and holding), United Kingdom and Ireland (insurance activities and holding), Spain (insurance activities and holdings), Italy (insurance activities), Prima (insurance activities), and AXA Life Europe (insurance activities) <sup>p. 47</sup>.
* '''AXA XL''' scope includes insurance and reinsurance activities and holding <sup>p. 47</sup>.
* '''AXA XL''' includes insurance and reinsurance activities and holding <sup>p. 47</sup>.
* '''Asia, Africa & EME-LATAM''' scope includes:
* '''Asia, Africa & EME-LATAM''' includes:
** '''Asia''': Japan (insurance and holding), Hong Kong (insurance), Thailand P&C, China P&C, South Korea, and Asia Holdings (all fully consolidated); China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed March 11, 2024 and holding) businesses (consolidated under equity method, contributing only to NBV, PVEP, underlying earnings, and net income) <sup>p. 47</sup>.
** '''Asia''': Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings which are fully consolidated; and China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024 and holding) businesses which are consolidated under the equity method and contribute only to NBV, PVEP, the underlying earnings, and net income <sup>p. 47</sup>.
** '''Africa''': Morocco (insurance and holding), Nigeria (insurance and holding), and Egypt (insurance and holding) (all fully consolidated) <sup>p. 47</sup>.
** '''Africa''': Morocco (insurance activities and holding), Nigeria (insurance activities and holding), and Egypt (insurance activities and holding) which are fully consolidated <sup>p. 47</sup>.
** '''EME-LATAM''': Mexico (insurance), Colombia (insurance), Brazil (insurance and holding), and Türkiye (insurance and holding) (all fully consolidated); Russia (Reso) (insurance) (consolidated under equity method, contributing only to net income) <sup>p. 47</sup>.
** '''EME-LATAM''': Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding), and Türkiye (insurance activities and holding) which are fully consolidated; as well as Russia (Reso) (insurance activities) which is consolidated under the equity method and contributes only to the net income <sup>p. 47</sup>.
** '''AXA Mediterranean Holdings''' <sup>p. 47</sup>.
** '''AXA Mediterranean Holdings''' <sup>p. 47</sup>.
* '''Transversal & Other''' scope includes AXA Assistance, AXA Liabilities Managers, AXA, and other Central Holdings <sup>p. 47</sup>.
* '''Transversal & Other''' includes AXA Assistance, AXA Liabilities Managers, AXA, and other Central Holdings <sup>p. 47</sup>.
* '''AXA Investment Managers''' (until July 1, 2025) scope includes AXA Investment Managers, Select (previously referred to as Architas), and Capza (all fully consolidated), and Asian joint ventures (consolidated under equity method) <sup>p. 47</sup>.
* '''AXA Investment Managers''' (until July 1, 2025) includes AXA Investment Managers, Select (previously referred to as Architas), and Capza which are fully consolidated, and Asian joint ventures which are consolidated under the equity method <sup>p. 47</sup>.
* '''Accounting standards''' note: unless otherwise specified, all comparative figures going back to 2023 are under IFRS17/9 standards effective January 1, 2023; periods prior to 2023 have not been restated and are presented under IFRS4 <sup>p. 47</sup>.
* '''Accounting standards''': Unless otherwise specified, all comparative figures going back to 2023 are under IFRS17/9 standards effective January 1, 2023; figures prior to 2023 have not been restated and are presented under IFRS4 <sup>p. 47</sup>.


=== Glossary ===
=== Glossary ===
Line 1,625: Line 1,572:
* '''Underlying return on in-force''': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup>
* '''Underlying return on in-force''': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup>


=== February 26, 2026 Thank you Full Year 2025 Earnings ===
=== February 26, 2026 Thank you Full Year 2025 earnings ===


* Concluding slide of the presentation <sup>p. 49</sup>.
* '''AXA Full Year 2025 Earnings''' presentation closing slide, dated February 26, 2026 <sup>p. 49</sup>
* '''Presentation title''': Full Year 2025 Earnings <sup>p. 49</sup>.
* '''Presentation date''': February 26, 2026 <sup>p. 49</sup>.


== Abbreviations ==
== Abbreviations ==


* '''AA''': S&P rating from 'AA-' to 'AA+'
* '''AA''': Senior bond rating
* '''AAA''': S&P rating from 'AAA-' to 'AAA+'
* '''AAA''': Senior bond rating
* '''ABS''': Asset-Backed Securities
* '''ABS''': Asset-Backed Securities
* '''AEP''': Aggregate Exceedance Probability
* '''AI''': Artificial Intelligence
* '''AI''': Artificial Intelligence
* '''APAC''': Asia-Pacific
* '''APAC''': Asia-Pacific
* '''APM''': Alternative Performance Measures
* '''APM''': Alternative Performance Measures
* '''AXA IM''': AXA Investment Managers
* '''AXA IM''': AXA Investment Managers
* '''AXA XL''': AXA XL, AXA's large property and casualty and specialty risk division
* '''AXA XL''': AXA XL (AXA's large property & casualty and specialty risk division)
* '''AY''': Accident Year
* '''AY''': Accident Year
* '''BBA''': Business Backing Annuities
* '''BBA''': Business By Account
* '''CDP''': Carbon Disclosure Project
* '''CDP''': Carbon Disclosure Project
* '''CLO''': Collateralized Loan Obligation
* '''CLO''': Collateralized Loan Obligation
Line 1,650: Line 1,594:
* '''CSM''': Contractual Service Margin
* '''CSM''': Contractual Service Margin
* '''CY''': Calendar Year
* '''CY''': Calendar Year
* '''DPS''': Dividends Per Share
* '''EME''': Europe, Middle East
* '''EME''': Emerging Markets
* '''EOF''': Eligible Own Funds
* '''EOF''': Eligible Own Funds
* '''EPS''': Earnings Per Share
* '''EPS''': Earnings Per Share
Line 1,660: Line 1,603:
* '''FX''': Foreign Exchange
* '''FX''': Foreign Exchange
* '''GAAP''': Generally Accepted Accounting Principles
* '''GAAP''': Generally Accepted Accounting Principles
* '''GEP''': Gross Earned Premium
* '''GBP''': Great British Pound
* '''GEP''': Gross Earned Premiums
* '''GWP''': Gross Written Premiums
* '''GWP''': Gross Written Premiums
* '''HKD''': Hong Kong Dollar
* '''HKD''': Hong Kong Dollar
Line 1,672: Line 1,616:
* '''LTV''': Loan-to-Value
* '''LTV''': Loan-to-Value
* '''MSCI''': Morgan Stanley Capital International
* '''MSCI''': Morgan Stanley Capital International
* '''MX''': Mexico
* '''NA''': North America
* '''NA''': North America
* '''NB CSM''': New Business Contractual Service Margin
* '''NB CSM''': New Business Contractual Service Margin
* '''NBV''': New Business Value
* '''NBV''': New Business Value
* '''NHG''': Nationale Hypotheek Garantie
* '''NHG''': Nationale Hypotheek Garantie (National Mortgage Guarantee)
* '''NPS''': Net Promoter Score
* '''NPS''': Net Promoter Score
* '''OCI''': Other Comprehensive Income
* '''OCI''': Other Comprehensive Income
* '''PAA''': Policyholder Annuity Assets
* '''PAA''': Premium Allocation Approach
* '''PE''': Private Equity
* '''PE''': Private Equity
* '''PVEP''': Present Value of Expected Profits
* '''PVEP''': Present Value of Expected Profits
* '''PYD''': Prior Years' Reserve Development
* '''PYD''': Prior Years' Reserve Development
* '''RCG''': Reclassification of Gains
* '''RCG''': Recurring Capital Gain
* '''ROE''': Return on Equity
* '''ROE''': Return on Equity
* '''SCR''': Solvency Capital Requirement
* '''SCR''': Solvency Capital Requirement
Line 1,692: Line 1,635:
* '''UK''': United Kingdom
* '''UK''': United Kingdom
* '''US''': United States
* '''US''': United States
* '''USD''': United States Dollar
* '''VAT''': Value Added Tax
* '''VAT''': Value Added Tax
* '''VFA''': Volatility Adjustment
* '''VFA''': Variable Fee Approach

Revision as of 14:42, 23 June 2026

Document info
OrganizationAXA
Year2025
PeriodFY
Period labelFY25
Document typeAnalyst presentation
Publication date2026-02-26
LanguageEnglish
Pages49
SourceOriginal URL

This article summarizes AXA's full-year 2025 earnings presentation, published on 26 February 2026.

Front matter

Full Year 2025 earnings presentation

  • Earnings presentation for Full Year 2025, delivered on February 26, 2026 p. 1

Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures

  • Forward-looking statements disclaimer covers predictions, plans, targets, and expectations, specifically noting that statements regarding expected underlying earnings per share (UEPS) growth for 2026 are forward-looking statements providing one-off guidance for the final year of the Group's current strategic plan p. 2.
  • Risk factors and uncertainties that may affect AXA's business are described in Part 5 "Risk Factors and Risk Management" of AXA's Universal Registration Document for the year ended December 31, 2024 p. 2.
  • Non-GAAP measures and alternative performance measures (APMs) used include "Underlying earnings", UEPS, "underlying return on equity", "combined ratio", and "debt gearing" p. 2.
  • APM reconciliations are provided in AXA's Activity Report as of December 31, 2025, under the heading "Use of non-GAAP and alternative performance measures" p. 2.
  • Financial statements for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of an audit procedure by statutory auditors p. 2.

Table of contents

  • FY25 Highlights presented by Thomas Buberl, Group CEO p. 3, 4
  • FY25 Business Performance presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology p. 3, 9
  • FY25 Financial Performance presented by Alban de Mailly Nesle, Group CFO p. 3, 13

FY25 Highlights

  • Section divider: FY25 Highlights presented by Thomas Buberl, Group CEO p. 4

Full Year 2025 | Excellent performance

Key financial highlights, FY25 p. 5
Metric Value
Revenues +6%
Underlying EPS +8%
Return on equity 16%
Solvency II ratio 224%
Dividend per share growth +8%
Share buyback EUR 1.25bn
Underlying EPS growth target for 2026 6% to 8% (upper end)
  • Revenues +6% vs. FY24 p. 5
  • Underlying EPS +8% vs. FY24 p. 5
  • Dividend per share +8% growth, based on the dividend proposed by AXA's Board of Directors on February 25, 2026, subject to approval by the Shareholders' Annual General Meeting on April 30, 2026 p. 5

Executing the plan on growth, margin and efficiency

Underlying earnings, FY24 vs FY25 p. 6
EUR billion unless otherwise mentioned FY24 FY25 Change (constant FX) Change (excluding AXA IM)
Underlying earnings 8.1 8.4 +6% +9%
  • Top line growth +6% at constant scope and FX, balanced across lines: P&C +5%, Life +9%, Health +5%
  • Margin expansion in P&C and L&H, alongside efficiency improvements
  • Business scaling supported by continued investments in growth and technology
  • Earnings growth remained consistent while enhancing reserve prudence

Diversified franchise, well positioned in an attractive industry

FY25 gross written premium split p. 7
Segment Share
Life 33%
Health 17%
Large & Specialty 17%
Retail 17%
SME & Mid-market 16%
  • Secular trends fuel demand across businesses, driven by protection gaps, emerging corporate risks, and demographics driving demand for private retirement and healthcare.
  • Our right to win is supported by four strategic pillars:
    • Leading brand & high customer NPS
    • Strong and diversified distribution
    • Technical expertise to price & underwrite risks
    • Scale offering cost advantage

Laying the foundation for the next plan

  • Strategic pillars established to lay the foundation for the next plan p. 8:
    • Clear tech and AI roadmap p. 8
    • Driving efficiency p. 8
    • Enhancing capital allocation discipline p. 8
    • Building resilience p. 8
  • Earnings growth outlook supported by these pillars, providing confidence in sustaining earnings growth p. 8

FY25 Business Performance

  • Section 2: FY25 Business Performance presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology p. 9.

Strong delivery across our businesses

  • Premium growth basis: change for gross written premiums is at constant scope and FX p. 10.
  • Earnings growth basis: change for underlying earnings is at constant FX p. 10.
  • Total GWP definition: FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers p. 10.
Business performance by region FY25 p. 10
Region Gross written premiums Underlying earnings
France (27% of total GWP¹) +6% to EUR 31bn +7% to EUR 2.2bn
Europe (38% of total GWP¹) +6% to EUR 43bn +9% to EUR 3.5bn
AXA XL (17% of total GWP¹) +4% to EUR 19bn +9% to EUR 1.9bn
Asia, Africa & EME-LATAM (18% of total GWP¹) +13% to EUR 20bn +6% to EUR 1.5bn

P&C | Strong margins, confidence in sustaining growth

  • (donut) Gross written premiums (GWP): EUR 58bn total; segments include Retail, AXA XL (Large & Specialty), and SME & Mid-market (shares not labeled) p. 11
    • AXA XL premiums include AXA XL Re premiums of EUR 2.6bn p. 11
  • Underlying earnings +9% at constant FX to EUR 5.9bn p. 11
  • Retail and SME & Mid-market strategic outlook:
    • 2025 focus: Growing volumes while expanding margins p. 11
    • Beyond 2025 focus: Investing to improve customer retention and expanding distribution footprint p. 11
  • AXA XL (Large & Specialty) strategic outlook:
    • 2025 focus: Profitable growth with stable margins p. 11
    • Beyond 2025 focus: Capitalizing on attractive growth opportunities and continued cycle management p. 11
  • Earnings growth drivers:
    • Continued progress on efficiency p. 11
    • Higher investment income p. 11
    • Data and AI utilization to further enhance customer experience and technical excellence p. 11

L&H | Good momentum, well positioned to capture growth opportunities

  • (donut) Gross written premiums (GWP): EUR 57bn total, split by Short-term and Long-term segments (shares not labeled) p. 12
  • Underlying earnings +7% LFL to EUR 3.5bn p. 12
  • Long-term business strategic priorities:
    • 2025: Accelerating net flows in Savings at attractive margins p. 12
    • Beyond 2025: Capturing savings & retirement opportunity, sourcing best asset management products for our customers p. 12
  • Short-term business strategic priorities:
    • 2025: Growing technical results while absorbing Mexico VAT impact p. 12
    • Beyond 2025: Capitalizing on demand for health & protection while further improving our margins p. 12
  • Strategic enablers:
    • Focus on cost reduction p. 12
    • Increasing penetration of Protection riders in Savings offerings p. 12
    • Leveraging AI to reduce claims leakage & improve customer outcomes in Health p. 12

FY25 Financial Performance

  • Section 3: FY25 Financial Performance presented by Alban de Mailly Nesle, Group CFO p. 13

P&C | Continued disciplined growth

GWP & other revenues by segment, FY24 vs FY25 p. 14
EUR billion unless otherwise mentioned FY24 FY25 Change LFL o/w pricing o/w volume
Commercial lines 35.8 +4% +2% +2%
AXA XL Reinsurance 2.6 +8% +0.3% +7%
Retail lines 19.7 +7% +5% +2%
Total GWP & other revenues 56.5 58.0 +5%
  • Continued pricing momentum and volume growth in Mid-market and SME p. 14.
  • Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance p. 14.
  • Growth supported by alternative capital p. 14.
  • Favorable pricing trends and strong growth in net new contracts with +1.7m in FY25 p. 14.

P&C | Delivering further margin expansion while enhancing reserve prudence

Combined ratio components, FY24 vs FY25 p. 15
Combined ratio FY24 FY25
Undiscounted CY loss ratio (ex Nat Cat) 67.4% 67.0%
Expense ratio 25.0% 24.8%
Nat Cat 3.8% 3.4%
Prior year reserve development -1.6% -1.1%
Discount -3.6% -3.5%
Total combined ratio 91.0% 90.6%
  • Undiscounted CY loss ratio (ex Nat Cat) improved from:
    • Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting a favorable pricing environment p. 15
    • Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management p. 15
  • Expense ratio improved reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology p. 15
  • Nat Cat charges were below the normalized load p. 15
  • Prior year reserve development showed lower reliance, taking advantage of a good year to enhance reserve prudence p. 15

P&C | Earnings growth from higher underwriting and financial result

Underlying earnings bridge, FY24 to FY25 p. 16
EUR million Underlying earnings
FY24 5,510
Underwriting result¹ (volume growth) +292
Underwriting result¹ (margin improvement) +189
Financial result (investment income) +435
Financial result (insurance finance expenses) -235
Tax -169
Affiliates, FX & other -150
FY25 5,872
  • Underlying earnings grew +9% at constant FX to EUR 5,872m p. 16.
  • Underwriting result improved from strong volume growth and improved all-year combined ratio while enhancing reserve prudence p. 16.
  • Investment income increased reflecting higher volumes and better reinvestment yields on fixed income assets p. 16.
  • Insurance finance expenses increased from higher unwind of discount of claims reserves, in line with guidance p. 16.
  • Forex impact was unfavorable, notably due to USD depreciation vs. EUR p. 16.

Life & Health | Strong growth in premiums, positive net flows

GWP & Other Revenues and Net Flows by segment, FY24 vs FY25 p. 17
EUR billion unless otherwise mentioned FY24 FY25 LFL Change
Life GWP & Other Revenues 34.5 37.5 +9%
Protection 17.3 +11%
Unit-linked 9.3 +13%
Capital light G/A 9.0 +7%
Traditional G/A 1.9 -7%
Health GWP & Other Revenues 17.5 19.0 +5%
Individual 10.5 +6%
Group 8.5 +4%
Employee Benefits GWP & Other Revenues 12.9 +4%
Net flows 1.5 5.4
Protection 4.9
Health 2.7
Unit-Linked 1.5
Capital light G/A 1.2
Traditional G/A -5.0

Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting

PVEP, NB CSM, NBV, and NBV margin, FY24 vs FY25 p. 18
EUR billion unless otherwise mentioned FY24 FY25 LFL Change
PVEP 50.9 49.4 -2%
Protection & Health 31.4 -4%
Unit-Linked 8.5 +18%
Capital-light G/A 7.8 -10%
Traditional G/A 1.7 -10%
NB CSM (pre-tax) 2.2 2.2 +3%
NBV (post-tax) 2.3 2.2 stable
NBV margin 4.4% 4.5%
  • PVEP impacted by higher interest rates on discounting despite strong growth in Life volumes.
  • NB CSM driven by robust Savings & Protection sales; reported growth impacted by higher interest rates for discounting of future profits.
  • NBV broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France.

Life & Health | Growth in new business driving Normalized CSM growth

Contractual Service Margin rollforward, FY24 to FY25 p. 19
EUR billion Contractual Service Margin
FY24 33.6
New business CSM +2.2
Underlying return on in-force +1.3
CSM release -3.0
Economic variance +0.6
Operating variance -0.3
Affiliates, FX & other -1.4
FY25 33.0
  • Normalized CSM up by +2% LFL, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates.
  • Economic variance reflecting government spreads tightening and positive equity market returns.
  • Operating variance driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland.
  • FX impact mainly from JPY and HKD depreciation.
  • Normalized CSM growth +2% (comprising New business CSM, Underlying return on in-force, and CSM release).
  • FY24 Life segment share: EUR 25.8bn
  • FY24 Health segment share: EUR 7.7bn
  • FY25 Life segment share: EUR 25.4bn
  • FY25 Health segment share: EUR 7.6bn

Life & Health | Strong momentum in both short-term and long-term business

Underlying earnings bridge, FY24 to FY25 p. 20
EUR million Underlying earnings
FY24 3,323
Short-term technical margin +60
Long-term result incl. CSM release +156
Financial result -11
Tax, FX and others -27
FY25 3,501
  • Underlying earnings +7% LFL to EUR 3,501m p. 20
  • Short-term technical margin: EUR 415m in FY24 to EUR 479m in FY25 p. 20
  • Long-term result incl. CSM release: EUR 2,680m in FY24 to EUR 2,804m in FY25 p. 20
  • Financial result: EUR 975m in FY24 to EUR 946m in FY25 p. 20
  • Tax & others: EUR -748m in FY24 to EUR -728m in FY25 p. 20
  • Life underlying earnings (o/w Life) grew to EUR 2.7bn (+4% vs. FY24; FY24 was EUR 2.6bn) p. 20
  • Health underlying earnings (o/w Health) grew to EUR 0.8bn (+17% vs. FY24; FY24 was EUR 0.7bn) p. 20
  • Short-term technical margin strong, reflecting underwriting and claims initiatives that more than offset the impact of legislative change on the recoverability of value added tax in Mexico of EUR -0.1bn p. 20
  • Long-term results higher from increase in CSM release (+8%) reflecting growth in reserve base, including from favorable equity market performance, and better margins p. 20

Growth in net income reflecting higher earnings & the gain from the sale of AXA IM

  • Underlying earnings driven by strong performance from insurance businesses p. 21
  • Holding cost stable, expected to remain at current level in 2026 p. 21
  • Net income increase mainly reflects higher underlying earnings and the gain from the sale of AXA IM p. 21
  • Financial flows lower, reflecting unfavorable forex impact p. 21
Earnings and net income bridge FY24 to FY25 (in EUR billion) p. 21
FY24 FY25 Change
Property & Casualty 5.5 5.9 +9%
Life & Health 3.3 3.5 +7%
Asset Management 0.4 0.2 -57%
Holdings & other -1.2 -1.2 -
Underlying earnings 8.1 8.4 +6%
Non-financial flows -0.5 +2.1
o/w capital gains from AXA IM disposal - +2.2
Financial flows (incl. RCG) +0.3 -0.7
Net income 7.9 9.8 +26%
  • (bar) Underlying earnings per share (in EUR): FY24 EUR 3.59 → FY25 EUR 3.86 (+8%) p. 21
    • Earnings growth contributed +6% p. 21
    • Capital management contributed +3% p. 21
    • Forex contributed -2% p. 21
    • AXA IM sale included -1% from temporary earnings dilution due to the timing of anti-dilutive share buyback p. 21

Shareholders' Equity

Shareholders' equity (Group share) and other metrics p. 22
EUR billion unless otherwise mentioned FY24 HY25 FY25
Shareholders' equity (total) 49.9 45.5 47.2
SHE (excl. OCI) 58.0 52.7 54.0
Net OCI -8.1 -7.2 -6.8
SHE (excl. OCI & undated subordinated debt) 53.2 47.0 49.4
Debt gearing 20.6% 23.4% 22.3%
Underlying ROE 15.2% 17.5% 16.0%
Shareholders' equity roll-forward (in Euro billion) p. 22
FY24 to FY25 HY25 to FY25
Opening Shareholders' equity 49.9 45.5
Change in Net OCI 1.3 0.4
Net income for the period 9.8 5.9
Dividend -4.6 -
Annual share buyback -1.2 -
Anti-dilutive share buyback following the sale of AXA IM -3.5 -3.5
Undated subordinated debt (including interest charges) -0.3 -1.2
Forex -3.5 -0.1
Other -0.6 0.3
Closing Shareholders' equity 47.2 47.2
  • Reporting currency is in Euro billion p. 22.

Higher organic cash remittance and robust cash position at Holding

  • Net cash remittance increased to EUR 7.5bn in FY25 p. 23
    • (bar) Net cash remittance trend: FY24 EUR 7.7bn (comprising EUR 7.1bn ordinary remittance and EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe) → FY25 EUR 7.5bn p. 23
    • Remittance ratio remained stable at 82% in FY24 and 82% in FY25, based on ordinary cash remittance of EUR 7.1bn in FY24 and EUR 7.5bn in FY25 p. 23
Holding cash position bridge FY24 to FY25 (in Euro billion) p. 23
FY24 Cash position 4.0
Net cash remittance from subsidiaries +7.5
Dividend -4.6
Annual share buyback -1.2
Anti-dilutive share buyback following the sale of AXA IM -3.5
Holding costs and interest expenses -1.3
Change in net debt +1.6
M&A and other +3.1
FY25 Cash position 5.6

Solvency II at 224%

Solvency II walk, FY24 to FY25 p. 24
EUR billion unless otherwise mentioned Eligible Own Funds Solvency Capital Requirement Solvency II ratio (pts)
FY24 55.9 25.9 216
Regulatory & model changes +0.2 0.0 +0
Normalized capital generation +8.8 +0.6 +28
Operating variance -0.4 0.0 -1
Economic variance & FX -2.1 -1.2 +4
Dividend & annual share buyback -6.0 0.0 -24
Management actions, debt & other -0.1 -0.2 +2
FY25 56.4 25.2 224
Solvency II sensitivities as of December 31, 2025 (base ratio 224%) p. 24
Sensitivity pts
Interest rate +50bps +2
Interest rate -50bps -1
Corporate spreads +50bps -1
Euro Sovereign spreads +50bps -7
Credit migration -4
Listed Equity (excl. PE & Infra) +25% -1
Listed Equity (excl. PE & Infra) -25% +2
PE & Infra +25% +14
PE & Infra -25% -19
Inflation swap curve +50bps -5
  • Solvency II ratio increased to 224% in FY25 (was 216% in FY24) p. 24.
  • Foreseeable dividends were EUR -4.8bn p. 24.
  • Provision for share buyback for 2026 was EUR -1.25bn p. 24.
  • Euro Sovereign spreads +50bps: (assumes 50bps spread widening of Euro sovereign bonds vs. Euro swap curve applied on sovereign and quasi-sovereign exposures) p. 24
  • Credit migration: (assumes 20% of corporate bonds, including private debt, held are downgraded by one full letter / 3 notches) p. 24

Solvency II -impact of the end of grandfathering period and Solvency II revision

Solvency II ratio evolution p. 25
Solvency II ratio Value
As of December 31, 2025 224%
Grandfathering end impact on January 1, 2026 -10pts to 215%
Solvency II revision impact to come into effect in 1Q27 +17pts
  • EUR 2.4bn grandfathered debt is no longer eligible as capital from January 1, 2026 p. 25.
  • Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date p. 25.
  • No change is expected in organic capital generation p. 25.
  • Provides additional capital flexibility p. 25.

Thomas Buberl, Group CEO conclusion

  • Conclusion presented by Thomas Buberl, Group CEO p. 26

Conclusion

  • Record results achieved at the top end of the target range while enhancing reserve prudence p. 27.
  • Business performance shows all businesses in excellent shape, delivering strong growth and profitability p. 27.
  • Diversified franchise is well-positioned to capture future growth opportunities p. 27.
  • Strategic outlook focused on laying foundations for the next plan and confident in delivering sustainable earnings growth p. 27.

February 26, 2026 Q&A Full Year 2025 earnings

  • Session title: Q&A Full Year 2025 Earnings, February 26, 2026 p. 28

AXA Investor Relations | Keep in touch

  • Investor Relations contact details: phone +33 1 40 75 48 42, email investor.relations@axa.com p. 29
  • Follow us on www.axa.com and social media channels p. 29
Meet our management event schedule p. 29
Date Event Location
March Roadshows Europe and US
May 5 1Q25 Activity Indicators Paris
June 2 BNP Paribas Exane CEO Conference Paris
June 2-4 Goldman Sachs European Financials Conference Zurich
July 31 HY26 Earnings Release Paris
September 21 AXA Investor Day London

Appendices

  • Section divider slide for Appendices p. 30.

Table of contents

  • Debt and Invested Assets p. 31
  • Additional P&C disclosures p. 36
  • Additional IFRS17 disclosures p. 41
  • Sustainability p. 44

Gross financial debt and maturity breakdown as of December 31st, 2025

  • Debt gearing was 20.6% in FY24 and 22.3% in FY25 p. 32.
  • (stacked bar) Gross financial debt (nominal debt):
    • FY24: EUR 19.2bn total; Tier 1 EUR 4.8bn, Tier 2 EUR 10.8bn, Senior debt EUR 3.5bn p. 32
    • FY25: EUR 20.3bn total; Tier 1 EUR 4.6bn, Tier 2 EUR 12.2bn, Senior debt EUR 3.5bn p. 32
    • Jan 1st 2026 (End of the grandfathering period): EUR 20.3bn total; Tier 1 EUR 3.2bn, Tier 2 EUR 11.3bn, Senior debt EUR 5.8bn (of which EUR 0.4bn redeemed in Jan 2026) p. 32
  • (stacked bar) Contractual maturity breakdown:
    • 2028: Senior debt EUR 0.5bn p. 32
    • 2030: Tier 2 EUR 0.7bn, Senior debt EUR 0.9bn p. 32
    • 2031-2039: Senior debt EUR 1.5bn p. 32
    • >=2040: Tier 2 EUR 10.8bn, Senior debt EUR 0.5bn p. 32
    • Undated: Tier 1 EUR 4.6bn, Tier 2 EUR 0.7bn p. 32
    • Of which grandfathered debt:
      • Tier 1: Undated EUR 1.4bn p. 32
      • Tier 2: 2030 EUR 0.7bn, >=2040 EUR 0.2bn p. 32
  • (stacked bar) Economic maturity breakdown:
    • 2026: Tier 1 EUR 0.1bn p. 32
    • 2027: Tier 2 EUR 2.4bn p. 32
    • 2028: Tier 1 EUR 0.1bn, Senior debt EUR 0.5bn p. 32
    • 2029: Tier 2 EUR 2.0bn p. 32
    • 2030: Tier 2 EUR 0.7bn, Senior debt EUR 0.9bn p. 32
    • 2031-2039: Tier 1 EUR 0.4bn, Tier 2 EUR 6.4bn, Senior debt EUR 1.5bn p. 32
    • >=2040: Senior debt EUR 0.5bn p. 32
    • Undated: Tier 1 EUR 4.0bn, Tier 2 EUR 0.7bn p. 32
    • Of which grandfathered debt:
      • Tier 1: 2026 EUR 0.1bn, 2028 EUR 0.1bn, 2031-2039 EUR 0.4bn, Undated EUR 0.8bn p. 32
      • Tier 2: 2030 EUR 0.7bn, 2031-2039 EUR 0.2bn p. 32
  • Debt calls in January 2026: AXA called the remaining Tier 2 grandfathered GBP 139m due 2054 callable 2034 5.625% issued January 2014, and the Tier 1 grandfathered EUR 250m perpetual callable 2010 floating issued January 2005 p. 32.
  • Economic maturity definition: Economic maturity takes into account the first date of step-up calls on institutionally placed subordinated debt p. 32. For Solvency II RT1 debt with no step-up, the undated nature of the instrument is retained p. 32.

General Account invested assets

  • Total General Account invested assets at EUR 450bn for FY25 p. 33
  • Duration gap at -0.4 year p. 33
  • (donut) FY25 Total General Account invested assets: EUR 450bn total; segments include Fixed income, Real estate, Infrastructure equity, Listed equities, Private equity and hedge funds, Cash, and Policy loans p. 33
Invested assets (100%) in Euro billion p. 33
Invested assets (100%) In EUR billion unless otherwise mentioned FY25 %
Fixed income 345 77%
o/w Government bonds 167 37%
o/w Corporate bonds and loans 121 27%
o/w Other fixed income¹ 56 13%
Real estate 41 9%
Infrastructure equity 10 2%
Listed equities² 10 2%
Private equity and hedge funds³ 23 5%
Cash 19 4%
Policy loans 2 0%
Total Insurance Invested Assets⁴ 450 100%
  • Other fixed income includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn) p. 33
  • Listed equities includes hedges; listed equities excluding hedges at EUR 14bn p. 33
  • Private equity and hedge funds includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn) p. 33

Structured and Private Credit assets

Structured and Private Credit assets FY25 p. 34
Invested assets (100%) In EUR billion unless otherwise mentioned FY25 % of total G/A¹ portfolio Comments
Residential Mortgages 16 4% - EUR 6bn Dutch mortgages, NHG guaranteed - EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)
CLO & ABS 25 6% - 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)
Infrastructure debt 8 2% - Skewed towards resilient industries (Telecom, Utilities, Transport)
CRE debt 8 2% - Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV
Mid-Market lending 10 2% - Strong diversification with EUR 8m average ticket - Investments through SMAs with strict underwriting guidelines : senior secured, covenants, restrictions on asset sales and sector allocation
Other 2 0%
Total Structured and Private Credit Assets 69 15% o/w 54% participating
  • General Account (G/A) refers to General Account p. 34.

Investment portfolio | Fixed Income reinvestment

  • Fixed income reinvestment totaled EUR 57bn in FY25 p. 35
  • (donut) FY25 Fixed income reinvestment asset mix:
    • Government bonds & related: 32% (average rating: AA) p. 35
    • Investment grade credit: 40% (average rating: A) p. 35
    • ABS/CLO/IG fund financing: 21% p. 35
    • Below investment grade credit: 7% p. 35
  • (bar) FY25 Fixed income reinvestment yield:
    • Public fixed income: 3.5% p. 35
    • Private & Structured fixed income: 4.7% p. 35
    • Total fixed income: 3.9% p. 35
  • Reinvestment yield achieved at 3.9% on EUR 57bn invested p. 35:
    • Average duration of 9 years p. 35
    • Includes EUR 19.7bn of Private & Structured Credit invested at 4.7% (CLOs, ABS, Infra & CRE debt, Fund financing and Private HY) p. 35
    • Gradual shift from alternative total return assets to Private & Structured credit p. 35

Table of contents

AXA XL Insurance | Large Commercial & Specialty business

FY25 GWP by line of business and geography p. 37
USD billion unless otherwise mentioned Casualty Property Specialty Professional lines (including Cyber) Americas Europe & APAC UK & Lloyds
FY25 GWP 19
Share 35% 29% 19% 17% 46% 35% 19%
  • Market leadership positions AXA XL in the top 3 globally for p. 37:
    • Multinational Programs p. 37
    • Marine p. 37
    • Fine Art & Specie p. 37
  • Cycle management is utilized to deliver consistent profitability p. 37:
    • (bubble chart) Profitability vs Ex-price growth (%): shows relative positioning of key lines p. 37:
      • Property: high profitability, high ex-price growth p. 37
      • Specialty: moderate-high profitability, moderate ex-price growth p. 37
      • Casualty: moderate profitability, moderate ex-price growth p. 37
      • Professional lines: lower profitability, lower ex-price growth p. 37

P&C | Focus on Reserves

Claims and Technical reserves ratio p. 38
% FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25
Claims reserves ratio (IFRS4 basis) 179% 185% 193% 188% 189%
Claims reserves ratio (IFRS17 basis) 198% 195% 180% 175%
Technical reserves ratio (IFRS4 basis) 213% 227% 233% 226% 227%
Technical reserves ratio (IFRS17 basis) 234% 232% 216% 210%
  • ¹ Includes net undiscounted claims reserves and unearned premium reserves p. 38.

P&C | 2026 Simplified Group Nat Cat Reinsurance Program 1

Insurance segment occurrence protection capacity and retention by peril p. 39
Peril Capacity Retention
EU Windstorm EUR 4.0bn EUR 600m
Europe Flood EUR 2.1bn EUR 450m
Europe Earthquake EUR 2.1bn EUR 400m
NA Hurricane EUR 1.2bn EUR 600m
NA Earthquake EUR 1.2bn EUR 600m
Per other perils EUR 400m
  • Retention levels remained stable in 2026 compared to 2025 p. 39.
  • (diagram) Reinsurance segment (illustrative) utilizes Alternative Capital & Cat Bonds p. 39.

P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026

Group underlying earnings deviation to average Nat Cat charges in 2026 net of reinsurance, post-tax p. 40
Percentile EUR billion
1/20y (95th percentile) -1.2
1/10y (90th percentile) -0.8
1/5y (80th percentile) -0.4
Median (50th percentile) +0.1
1/5y (20th percentile) +0.5
1/10y (10th percentile) +0.7
1/20y (5th percentile) +0.8
Average expected Nat Cat charges net of reinsurance, pre-tax p. 40
Year EUR billion Estimated impact on GEP
2025 2.6 ca. 4.5%
2026 2.7 ca. 4.5%
  • Earnings deviation from average Nat Cat charges in 2026 (net of reinsurance, post-tax) shows asymmetric distribution p. 40:
    • More severe years result in negative deviation in ca. 40% of cases p. 40.
    • Less severe years result in positive deviation in ca. 60% of cases p. 40.

Table of contents

P&C | Margin analysis

P&C Underlying Earnings Bridge FY25 p. 42
Metric FY25 Change
Underlying earnings before tax EUR 8,040m +EUR 681m
Tax -EUR 2,060m -EUR 169m
Affiliates, minority interests & other -EUR 108m -EUR 10m
Underlying earnings EUR 5,872m +EUR 501m
Growth vs. FY24 (at constant FX) +9%
P&C margin bridge components (in EUR million, pre-tax, changes versus FY24 at constant FX) p. 42
Component Value Change Other metrics
Current accident year undiscounted technical margin 2,778 +707 Gross earned premiums: EUR 57,656m (+6%); Current accident year undiscounted combined ratio: 95.2% (-1.0pt); o/w Nat Cats: 3.4% (-0.4pt)
Current accident year discounting 2,009 +115 Discounting ratio (in combined ratio points): -3.5% (+0.0pt); Current accident year net claims reserves: EUR 19.0bn; Duration: 4.0 years; Current accident year discount rate: 2.8%
Prior years' reserve development (PYD) 622 -341 PYD ratio: -1.1% (+0.7pt)
Investment income 3,988 +435 FY25 average assets: EUR 115bn; Asset book yield: 3.5%; FY25 reinvestment yield (on fixed income assets): 4.3%
Insurance finance expenses -1,358 -235 FY24 reserves at locked-in rate: EUR 71bn; Liability book yield: 1.9%
FY25 sensitivity to current accident year discount rate changes p. 42
Change in discount rate Impact (EUR billion)
+25bps +0.2
-25bps -0.2
Sensitivity of 2026e insurance finance expenses to changes in 2025 current AY discount p. 42
Change in 2025 current AY discount Impact (EUR million)
+25bps ~-50
-25bps ~+50
  • Technical result and Financial result components sum to underlying earnings before tax p. 42.
  • 2026e insurance finance expenses (pre-tax): ~-EUR 1.4bn p. 42

L&H | Margin analysis

Life & Health FY25 CSM Key Sensitivities (in Euro billion) p. 43
Sensitivity Impact on CSM
Baseline 33.3
Interest rates +50bps -0.8
Interest rates -50bps 0.6
Sovereign spreads +50bps -1.9
Sovereign spreads -50bps 1.9
Corporate spread +50bps -0.8
Corporate spread -50bps 0.7
Equities +25% 1.8
Equities -25% -2.2
Life & Health Financials (pre-tax) p. 43
Metric Value LFL Change Other metrics
Short-term Technical Margin EUR 479m +EUR 60m Gross earned premiums: EUR 17,416m (+10% LFL); All year combined ratio: 97.2% (-0.1pts)
Long-term Technical Margin EUR 2,804m +EUR 156m CSM release: EUR 2,954m (+EUR 215m LFL); Technical experience: EUR -150m (-EUR 58m LFL)
Investment Income (non-VFA only) EUR 2,484m -EUR 1m Average assets: EUR 98bn; Asset book yield: 2.5%; Reinvestment yield: 3.8% on fixed income assets
Insurance Finance Expenses (non-VFA only) EUR -1,538m -EUR 9m Reserves at locked-in rate: EUR 62bn (FY24); Liability book yield: 2.5%
Underlying Earnings before tax EUR 4,229m +EUR 205m Tax: EUR -800m (+EUR 65m LFL); Affiliates, minority interests & other: EUR 72m (-EUR 51m LFL)
Underlying Earnings EUR 3,501m +EUR 219m +7% at constant FX

Table of contents

Expanding AXA's role in society: AXA for Progress Index 1

ESG Targets and 2025 Results p. 45
Category Target 2025 Result
Climate transition financing EUR 5bn per year EUR 6.4bn
Community resilience financing >EUR 500m per year EUR 1.4bn
Transition underwriting EUR 6bn in P&C GWP (cumulative 2024-2026) EUR 4.6bn
Climate adaptation solutions >20,000 (cumulative 2024-2026) 19,698 cumulative 2024-2025
Inclusive insurance customers >20m by 2026 20.6m
Climate adaptation training >80,000 employees trained by 2026 46,420
Carbon emissions reduction -50% by 2030 -64% reduction against 2019
Employee volunteering 50% of employees engaged by 2026 56%

Sustainability Performance & Ratings

ESG Ratings and Scores p. 46
Rating Agency 2025 Score
S&P Global 97th percentile in Dow Jones Best-in-Class Europe & World indices
MSCI AAA
CDP B
Morningstar Sustainalytics 17.0 - Low risk
FTSE Russell 4.3/5 in FTSE4Good Index Series
  • The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (specifically AXA Restricted Shares), with results as of February 6th, 2026.

Scope

  • France includes insurance activities, banking activities, and holding p. 47.
  • Europe includes Switzerland (insurance activities), Germany (insurance activities and holding), Belgium and Luxemburg (insurance activities and holding), United Kingdom and Ireland (insurance activities and holding), Spain (insurance activities and holdings), Italy (insurance activities), Prima (insurance activities), and AXA Life Europe (insurance activities) p. 47.
  • AXA XL includes insurance and reinsurance activities and holding p. 47.
  • Asia, Africa & EME-LATAM includes:
    • Asia: Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings which are fully consolidated; and China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024 and holding) businesses which are consolidated under the equity method and contribute only to NBV, PVEP, the underlying earnings, and net income p. 47.
    • Africa: Morocco (insurance activities and holding), Nigeria (insurance activities and holding), and Egypt (insurance activities and holding) which are fully consolidated p. 47.
    • EME-LATAM: Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding), and Türkiye (insurance activities and holding) which are fully consolidated; as well as Russia (Reso) (insurance activities) which is consolidated under the equity method and contributes only to the net income p. 47.
    • AXA Mediterranean Holdings p. 47.
  • Transversal & Other includes AXA Assistance, AXA Liabilities Managers, AXA, and other Central Holdings p. 47.
  • AXA Investment Managers (until July 1, 2025) includes AXA Investment Managers, Select (previously referred to as Architas), and Capza which are fully consolidated, and Asian joint ventures which are consolidated under the equity method p. 47.
  • Accounting standards: Unless otherwise specified, all comparative figures going back to 2023 are under IFRS17/9 standards effective January 1, 2023; figures prior to 2023 have not been restated and are presented under IFRS4 p. 47.

Glossary

  • Capital-light G/A products: encompass all products with no guarantees, with guarantees at maturity only or with guarantees equal to or lower than 0% p. 48
  • Contractual Service Margin (CSM): a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders p. 48
  • CSM release: a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss representing the estimated profit earned by the insurer for providing insurance services during the reporting period p. 48
  • Economic variance: corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force p. 48
  • Financial result: consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder's equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow p. 48
  • Gross Written Premiums and Other Revenues (GWP & Other Revenues): represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business). Other Revenues represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities) p. 48
  • New Business Value (NBV): the value of newly issued contracts during the current year. It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests p. 48
  • New Business Contractual Service Margin (NB CSM): a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided p. 48
  • New Business Value margin (NBV margin): ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP p. 48
  • Operating variance: the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes. Operating variance is net of reinsurance p. 48
  • Present value of expected premiums (PVEP): the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term. PVEP is discounted at the reference interest rate and PVEP is Group share p. 48
  • Technical experience: consists of the impacts on the underlying earnings of (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses p. 48
  • Underlying return on in-force: represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance p. 48

February 26, 2026 Thank you Full Year 2025 earnings

  • AXA Full Year 2025 Earnings presentation closing slide, dated February 26, 2026 p. 49

Abbreviations

  • AA: Senior bond rating
  • AAA: Senior bond rating
  • ABS: Asset-Backed Securities
  • AI: Artificial Intelligence
  • APAC: Asia-Pacific
  • APM: Alternative Performance Measures
  • AXA IM: AXA Investment Managers
  • AXA XL: AXA XL (AXA's large property & casualty and specialty risk division)
  • AY: Accident Year
  • BBA: Business By Account
  • CDP: Carbon Disclosure Project
  • CLO: Collateralized Loan Obligation
  • CRE: Commercial Real Estate
  • CSA: Corporate Sustainability Assessment
  • CSM: Contractual Service Margin
  • CY: Calendar Year
  • EME: Europe, Middle East
  • EOF: Eligible Own Funds
  • EPS: Earnings Per Share
  • ESG: Environmental, Social, and Governance
  • EU: European Union
  • EUR: Euro
  • FTSE: Financial Times Stock Exchange
  • FX: Foreign Exchange
  • GAAP: Generally Accepted Accounting Principles
  • GBP: Great British Pound
  • GEP: Gross Earned Premiums
  • GWP: Gross Written Premiums
  • HKD: Hong Kong Dollar
  • HY: High Yield
  • IFE: Insurance Finance Expenses
  • IFRS: International Financial Reporting Standards
  • IG: Investment Grade
  • JPY: Japanese Yen
  • LATAM: Latin America
  • LFL: Like-for-Like
  • LTV: Loan-to-Value
  • MSCI: Morgan Stanley Capital International
  • NA: North America
  • NB CSM: New Business Contractual Service Margin
  • NBV: New Business Value
  • NHG: Nationale Hypotheek Garantie (National Mortgage Guarantee)
  • NPS: Net Promoter Score
  • OCI: Other Comprehensive Income
  • PAA: Premium Allocation Approach
  • PE: Private Equity
  • PVEP: Present Value of Expected Profits
  • PYD: Prior Years' Reserve Development
  • RCG: Recurring Capital Gain
  • ROE: Return on Equity
  • SCR: Solvency Capital Requirement
  • SHE: Shareholders' Equity
  • SME: Small and Medium-sized Enterprises
  • TVOG: Time Value of Options & Guarantees
  • UEPS: Underlying Earnings Per Share
  • UK: United Kingdom
  • US: United States
  • VAT: Value Added Tax
  • VFA: Variable Fee Approach